U.S. patent application number 09/817491 was filed with the patent office on 2001-08-30 for chemical synthesis using solvent microdroplets.
This patent application is currently assigned to University of Washington. Invention is credited to Blanchard, Alan P..
Application Number | 20010018512 09/817491 |
Document ID | / |
Family ID | 26677820 |
Filed Date | 2001-08-30 |
United States Patent
Application |
20010018512 |
Kind Code |
A1 |
Blanchard, Alan P. |
August 30, 2001 |
Chemical synthesis using solvent microdroplets
Abstract
The present invention relates to microdroplets of a solution
comprising a solvent having a boiling point of 150.degree. C. or
above, a surface tension of 30 dynes/cm or above, and a viscosity
of 0.015 g/(cm)(sec). Such microdroplets are useful for the
synthesis of chemical species, particularly biopolymers such as
oligonucleotides and peptides, as well as arrays of chemical
species. Preferably, the solvent has the formula (I): 1 wherein A=O
or S; X, O, S or N(C.sub.1-C.sub.4 alkyl); Y=O, S,
N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and R=C.sub.1-C.sub.20
straight or branched chain alkyl.
Inventors: |
Blanchard, Alan P.;
(Seattle, WA) |
Correspondence
Address: |
CAMPBELL & FLORES LLP
4370 LA JOLLA VILLAGE DRIVE
7TH FLOOR
SAN DIEGO
CA
92122
US
|
Assignee: |
University of Washington
|
Family ID: |
26677820 |
Appl. No.: |
09/817491 |
Filed: |
March 26, 2001 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
09817491 |
Mar 26, 2001 |
|
|
|
09510270 |
Feb 22, 2000 |
|
|
|
09510270 |
Feb 22, 2000 |
|
|
|
09008120 |
Jan 16, 1998 |
|
|
|
09510270 |
Feb 22, 2000 |
|
|
|
08821156 |
Mar 20, 1997 |
|
|
|
6028189 |
|
|
|
|
Current U.S.
Class: |
536/25.3 ;
422/131; 536/23.1; 536/24.3 |
Current CPC
Class: |
B01J 2219/00527
20130101; C07H 21/00 20130101; B01J 2219/00585 20130101; B01J
2219/00378 20130101; B01J 2219/00475 20130101; C40B 50/14 20130101;
B01J 2219/00689 20130101; B01J 2219/00619 20130101; C07K 1/02
20130101; C07K 1/04 20130101; B01J 2219/00722 20130101; C40B 40/06
20130101; B82Y 30/00 20130101; B41J 2/01 20130101; B01J 2219/00695
20130101; B01J 2219/00691 20130101; B01J 19/0046 20130101; B01J
2219/00626 20130101; B01J 2219/00536 20130101; B01J 2219/00605
20130101; B01J 2219/00596 20130101; B01J 2219/0059 20130101; B01J
2219/00488 20130101; B01J 2219/00637 20130101; B01J 2219/0061
20130101; B01J 2219/00704 20130101; C07H 19/00 20130101; B01J
2219/00675 20130101; B01J 2219/00612 20130101; B01J 2219/00659
20130101 |
Class at
Publication: |
536/25.3 ;
536/23.1; 536/24.3; 422/131 |
International
Class: |
C07H 021/02; C07H
021/04; C07H 021/00; C08F 002/00; B32B 005/02; B32B 027/12; B32B
027/04 |
Goverment Interests
[0001] This invention was made with government support under grant
number BIR92-14821 awarded by the National Science Foundation. The
government has certain rights in the invention.
Claims
What is claimed is:
1. A microdroplet of a solution, the solution comprising a solvent
having a boiling point of 150.degree. C. or above, a surface
tension of 30 dynes/cm or above, and a viscosity of 0.015
g/(cm)(sec) or above.
2. The microdroplet of claim 1, wherein the solvent has the formula
(I): 5wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4 alkyl); Y=O, S,
N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and R=C.sub.1-C.sub.20
straight or branched chain alkyl.
3. The microdroplet of claim 2, wherein the solvent is selected
from the group consisting of: N-methyl-2-pyrrolidone;
2-pyrrolidone; propylene carbonate; .gamma.-valerolactone;
6-caprolactam; ethylene carbonate; .gamma.-butyrolactone;
.delta.-valerolactone; 1,3-dimethyl-3,4,5,6-tetrah-
ydro-2(1H)-pyrimidinone; ethylene trithiocarbonate; and
1,3-dimethyl-2-imidazolidinone.
4. The microdroplet of claim 2, wherein said solvent is propylene
carbonate.
5. The microdroplet of claim 1, wherein the volume of said
microdroplet is 100 pL or less.
6. The microdroplet of claim 5, wherein the volume of said
microdroplet is 50 pL or less.
7. The microdroplet of claim 1, wherein the solution comprises a
nucleoside or activated nucleoside.
8. The microdroplet of claim 7, wherein the solution comprises an
activated nucleoside that contains an activated
phosphorous-containing groups selected from the group consisting of
phosphodiester, phosphotriester, phosphate triester, H-phosphonate
and phosphoramidite groups.
9. A method for chemical synthesis, comprising the step of
dispensing a microdroplet of a solution comprising (i) a first
chemical species, and (ii) a solvent, such that the microdroplet
impinges a second chemical species and the first chemical species
reacts with the second chemical species to form a third chemical
species, the solvent having a boiling point of 150.degree. C. or
above, a surface tension of 30 dynes/cm or above, and a viscosity
of 0.015 g/(cm)(sec) or above.
10. The method of claim 9, wherein said solvent has the formula
(I): 6wherein A=O or S; O, S or N(C.sub.1-C.sub.4 alkyl); Y=O, S,
N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and R=C.sub.1-C.sub.20
straight or branched chain alkyl.
11. The method of claim 10, wherein the solvent is selected from
the group consisting of: N-methyl-2-pyrrolidone; 2-pyrrolidone;
propylene carbonate; .gamma.-valerolactone; 6-caprolactam; ethylene
carbonate; .gamma.-butyrolactone; .delta.-valerolactone;
1,3-dimethyl-3,4,5,6-tetrah- ydro-2(1H)-pyrimidinone; ethylene
trithiocarbonate; and 1,3-dimethyl-2-imidazolidinone.
12. The method of claim 10, wherein said solvent is propylene
carbonate.
13. The method of claim 9, wherein the volume of said microdroplet
is 100 pL or less.
14. The method of claim 13, wherein the volume of said microdroplet
is 50 pL or less.
15. The method of claim 9, wherein the third chemical species is
formed in the presence of a catalyst.
16. The method of claim 9, further comprising the step of
dispensing a microdroplet of a solution comprising (i) a catalyst
and (ii) the solvent, such that the microdroplet comprising the
catalyst and solvent impinges the second chemical species
subsequent to impingement by the microdroplet that comprises the
first chemical species and solvent.
17. The method of claim 9, wherein the second chemical species is
attached to a substrate, directly or via a linker molecule.
18. The method of claim 17, wherein the substrate is selected from
the group consisting of glass, silica, silicon, polypropylene,
TEFLON.RTM., polyethylimine, nylon, fiberglass, paper and
polystyrene.
19. The method of claim 17, wherein the second chemical species is
attached to a linker that is attached to the substrate.
20. The method of claim 9, wherein the first chemical species and
second chemical species are nucleosides or activated
nucleosides.
21. The method of claim 20, wherein the chemical species comprises
an activated nucleoside that contains activated
phosphorous-containing groups selected from the group consisting of
phosphodiester, phosphotriester, phosphate triester, H-phosphonate
and phosphoramidite groups.
22. The method of claim 9, wherein the chemical being synthesized
is an oligonucleotide or a peptide.
23. The method of claim 22, wherein the chemical being synthesized
is an oligodeoxyribonucleotide or an oligoribonucleotide.
24. A method for synthesizing an oligonucleotide, comprising the
steps of: (a) dispensing a first microdroplet of a solution
comprising (i) a first nucleoside having a phosphoramidite group at
its 3' position, and a protecting group at its 5' position and (ii)
a solvent having a boiling point of 150.degree. C. or above, a
surface tension of 30 dynes/cm or above, and a viscosity of 0.015
g/(cm)(sec) or above, such that the microdroplet impinges a
substrate with a linker attached thereto having hydroxyl groups,
and forms a microdot upon the substrate; (b) dispensing a second
microdroplet of a solution comprising (i) a catalyst and (ii) the
solvent, such that the second microdroplet impinges the microdot
and facilitates a reaction between the phosphoramidite group of the
first nucleoside and an hydroxyl group of the linker, resulting in
the conversion of the phosphoramidite group to a 3' phosphite
group, and the presence of unreacted hydroxyl groups of the linker;
(c) washing the substrate with an oxidizing agent to convert the 3'
phosphite group to a 3' phosphate group; (d) rinsing the substrate
with a deprotecting agent which removes the protecting group from
the 5' position of the first nucleoside, and yields a 5' hydroxyl
group; (e) dispensing a third microdroplet of a solution comprising
(i) a second nucleoside having a phosphoramidite group at its 3'
position, and a protecting group at its 5' position and (ii) the
solvent, such that the second microdroplet impinges the microdot;
and (f) dispensing a fourth microdroplet of a solution comprising
(i) the catalyst and (ii) the solvent, such that the fourth
microdroplet impinges the microdot and facilitates a reaction
between the phosphoramidite group of the second nucleoside and the
5' hydroxyl group of the first nucleoside, resulting in the
coupling of the second nucleoside to the first nucleoside.
25. The method of claim 24 further comprising the steps of
performing successive iterations of steps (c)-(f).
26. The method of claim 24, further comprising after step (c) and
before step (d) the step of treating the substrate with a capping
reagent which caps the unreacted hydroxyl groups of the linker.
27. The method of claim 26, wherein the capping reagent is
perfluorooctanoyl chloride.
28. The method of claim 24 wherein said solvent has the formula
(I): 7wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4 alkyl); Y=O, S,
N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and R=C.sub.1-C.sub.20
straight or branched chain alkyl.
29. The method of claim 28, wherein the solvent is selected from
the group consisting of: N-methyl-2-pyrrolidone; 2-pyrrolidone;
propylene carbonate; .gamma.-valerolactone; 6-caprolactam; ethylene
carbonate; .gamma.-butyrolactone; .delta.-valerolactone;
1,3-dimethyl-3,4,5,6-tetrah- ydro-2(1H)-pyrimidinone; ethylene
trithiocarbonate; and 1,3-dimethyl-2-imidazolidinone.
30. The method of claim 28, wherein said solvent is propylene
carbonate.
31. The method of claim 24, wherein the substrate is glass.
32. The method of claim 24, wherein the catalyst is
5-ethylthiotetrazole.
33. The method of claim 24, wherein the oxidizing agent is a
solution comprising iodine and water.
34. An array of microdots on a substrate, said microdots comprising
(i) a chemical species, and (ii) a solvent having a boiling point
of 150.degree. C. or above, a surface tension of 30 dynes/cm or
above, and a viscosity of 0.015 g/(cm)(sec) or above.
35. The array of claim 34, wherein said solvent has the formula
(I): 8wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4 alkyl); Y=O, S,
N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and R=C.sub.1-C.sub.20
straight or branched chain alkyl.
36. The array of claim 35, wherein the solvent is selected from the
group consisting of: N-methyl-2-pyrrolidone; 2-pyrrolidone;
propylene carbonate; .gamma.-valerolactone; 6-caprolactam; ethylene
carbonate; .gamma.-butyrolactone; .delta.-valerolactone;
1,3-dimethyl-3,4,5,6-tetrah- ydro-2(1H)-pyrimidinone; ethylene
trithiocarbonate; and 1,3-dimethyl-2-imidazolidinone.
37. The array of claim 35, wherein said solvent is propylene
carbonate.
38. The array of claim 34, wherein each of said microdots has a
diameter in the range of 1 to 1000 .mu.m.
39. The array of claim 38, wherein each of said microdots has a
diameter in the range of 10 to 500 .mu.m.
40. The array of claim 39, wherein each of said microdots has a
diameter in the range of 40 to 100 .mu.m.
41. The array of claim 34, wherein the chemical species is an
oligonucleotide or a peptide.
42. The array of claim 41, wherein the chemical species is an
oligodeoxyribonucleotide or an oligoribonucleotide.
43. The array of claim 34, wherein the microdots are separated from
each other by hydrophobic domains.
44. An automated system comprising: an inkjet print head for
spraying a microdroplet comprising a chemical species on a
substrate; a scanning transport for scanning the substrate adjacent
to the print head to selectively deposit the microdroplet at
specified sites; a flow cell for treating the substrate on which
the microdroplet is deposited by exposing the substrate to one or
more selected fluids; a treating transport for moving the substrate
between the print head and the flow cell for treatment in the flow
cell; and an alignment unit for aligning the substrate correctly
relative to the print head each time when the substrate is
positioned adjacent to the print head for deposition.
45. The system of claim 44, wherein the inkjet printhead contains a
solution comprising the chemical species dissolved in a
solvent.
46. The system of claim 45, wherein the chemical species is a
monomer unit of a biopolymer.
47. The system of claim 45, wherein the solution further comprises
a catalyst.
48. The system of claim 45 wherein the solution comprises a solvent
having a boiling point of 150.degree. C. or above, a surface
tension of 30 dynes/cm or above, and a viscosity of 0.015
g/(cm)(sec) or above.
49. The system of claim 48, wherein the solvent has the formula
(I): 9wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4 alkyl); Y=O, S,
N(C.sub.1-C.sub.4) or CH.sub.2; and R=C.sub.1-C.sub.20 straight or
branched chain alkyl.
50. The system of claim 49, wherein the solvent is selected from
the group consisting of: N-methyl-2-pyrrolidone; 2-pyrrolidone;
propylene carbonate; .gamma.-valerolactone; 6-caprolactam; ethylene
carbonate; .gamma.-butyrolactone; .delta.-valerolactone;
1,3-dimethyl-3,4,5,6-tetrah- ydro-2(1H)-pyrimidinone; ethylene
trithiocarbonate; and 1,3-dimethyl-2-imidazolidinone.
51. The system of claim 48, wherein said solvent is propylene
carbonate.
52. The system of claim 46 which is for synthesizing an
oligonucleotide, and wherein the monomer is a nucleoside or
nucleoside derivative.
53. The system of claim 52, wherein the nucleoside is a
deoxyribonucleoside or a ribonucleoside.
54. The system of claim 44, wherein the inkjet print head comprises
an array of piezoelectric pumps.
55. The system of claim 54, further comprising an external
reservoir connected to supply the chemical species to the print
head.
56. The system of claim 55, wherein the external reservoir contains
a solution comprising the chemical species dissolved in a
solvent.
57. The system of claim 56, wherein the solvent has a boiling point
of 150.degree. C. or above, a surface tension of 30 dynes/cm or
above, and a viscosity of 0.015 g/(cm)(sec) or above.
58. The system of claim 57, wherein the solvent has the formula
(I): 10wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4 alkyl); Y=O,
S, N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and R=C.sub.1-C.sub.20
straight or branched chain alkyl.
59. The system of claim 58, wherein the solvent is selected from
the group consisting of: N-methyl-2-pyrrolidone; 2-pyrrolidone;
propylene carbonate; .gamma.-valerolactone; 6-caprolactam; ethylene
carbonate; .gamma.-butyrolactone; .delta.-valerolactone;
1,3-dimethyl-3,4,5,6-tetrah- ydro-2(1H)-pyrimidinone; ethylene
trithiocarbonate; and 1,3-dimethyl-2-imidazolidinone.
60. The system of claim 58, wherein said solvent is propylene
carbonate.
61. An automated system for synthesizing oligonucleotides on a
substrate, comprising: an inkjet print head for spraying a solution
comprising a nucleoside or activated nucleoside on a substrate; a
scanning transport for scanning the substrate adjacent to the print
head to selectively deposit the nucleoside at specified sites; a
flow cell for treating the substrate on which the monomer is
deposited by exposing the substrate to one or more selected fluids;
a treating transport for moving the substrate between the print
head and the flow cell for treatment in the flow cell; and an
alignment unit for aligning the substrate correctly relative to the
print head each time when the substrate is positioned adjacent to
the print head for deposition.
62. The system of claim 61, wherein the inkjet print head comprises
an array of piezoelectric pumps.
63. The system of claim 61, further comprising: an external
reservoir connected to supply the nucleoside to the print head.
64. The system of claim 63, wherein the external reservoir contains
a solution comprising said nucleoside or activated nucleoside
dissolved in propylene carbonate.
65. The system of claim 61, further comprising a plurality of
external reservoirs connected to the printer head, each external
reservoir storing a nucleoside or activated nucleoside.
66. The system of claim 61, further comprising control logic
configured to perform the following steps: moving the substrate
over the print head with the scanning transport; firing the print
head repeatedly to deposit the nucleoside or activated nucleoside
monomer at the specified loci on the substrate; and transferring
the substrate to the flow cell with the treating transport.
67. The system of claim 61, wherein the scanning transport
comprises: a vacuum chuck for holding the substrate; and a
translational stage connected to move the vacuum chuck with respect
to the print head.
68. The system of claim 67, wherein the vacuum chuck is rotatable
for alignment with the print head.
69. The system of claim 68, wherein the vacuum chuck is engageable
by a stationary element to rotate the vacuum chuck for alignment
with the print head.
70. The system of claim 67, wherein the translational stage is
driven by motorized means.
71. The system of claim 70, wherein the motorized means is a
stepping motor.
72. The system of claim 61, wherein the flow cell has means for
rinsing off unconnected monomers.
73. The system of claim 61, wherein the treating transport
comprises: a vacuum chuck for holding the substrate; and a
translational stage connected to move the second vacuum chuck and
to move the substrate to and from the flow cell.
74. The system of claim 73, wherein the translational stage is
driven by motorized means.
75. The system of claim 74, wherein the motorized means is a
stepping motor.
76. The system of claim 61, wherein said alignment unit comprises a
camera positioned adjacent to the substrate to positionally
calibrate the substrate.
77. The system of claim 61, wherein said alignment unit comprises a
marker that can be activated to establish one or more marks at
particular loci on the substrate for positionally calibrating the
substrate.
78. The system of claim 61, wherein said alignment unit comprises:
a marker that can be activated to establish one or more marks at
particular loci on the substrate; and a camera positioned adjacent
to the substrate to located said marks relative to the printer
head.
79. The system of claim 78, further comprising a tip that can be
activated to scratch marks at particular loci on the substrate for
positionally calibrating the substrate.
80. The system of claim 61, wherein said alignment unit comprises:
control logic connected to control the movement of the scanning
transport; a marker that can be activated to establish one or more
marks at particular loci on the substrate; and a camera positioned
adjacent to the substrate to locate said marks relative to the
printer head.
81. The system of claim 80, wherein the control logic is configured
to perform the following steps: moving the substrate over the
marker to establish one or more marks on the substrate;
subsequently locating the marks with the camera; determining the
position of the substrate with respect to the print head with
reference to the marks; and calibrating the scanning transport in
response to the determined position of the substrate with respect
to the printer head.
82. The system of claim 80, further comprising a stationary element
that engages the substrate chuck to rotate the substrate chuck for
alignment with the print head, wherein the control logic is
configured to perform the following steps: moving the substrate
over the marker to establish one or more marks on the substrate;
subsequently locating the marks with the camera; determining
misalignment of the substrate relative to the print head with
reference to the marks; and moving the translational stage to (a)
engage the substrate chuck with the stationary element, and (b)
rotate the substrate chuck by an angular displacement that corrects
for the misalignment.
83. The system of claim 61, further comprising a transfer station
that supports the substrate for transfer between the treating
transport and the scanning transport.
84. A method of controlling a system synthesizing a biopolymer on a
substrate using a computer having a memory for storing a control
program and data, wherein the system has an inkjet print head for
spraying a microdroplet on the substrate, a scanning transport for
scanning the substrate adjacent to the print head to selectively
deposit the microdroplet, an alignment unit for detecting
misalignment of the substrate with respect to the print head at
each deposition step, a flow cell for treating the substrate, and a
treating transport for moving the substrate between the printer
head and the flow cell, the method comprising the steps of: (a)
aligning the substrate relative to the print head by processing
data from the alignment unit and by sending a signal to the
scanning transport to move the substrate so as to correct
misalignment of the substrate; (b) selectively depositing a
microdroplet on the substrate by sending a signal to the print head
to spray the microdroplet and by sending a signal to the scanning
transport to move the substrate adjacent to the print head so that
the microdroplet can be deposited at specified loci on the
substrate; and (c) controlling treatment of the substrate by
sending a signal to the treating transport to move the substrate to
the flow cell and by sending a signal to the flow cell to control
operation of the flow cell.
85. The method of claim 84, wherein the microdroplet comprises a
monomer unit of a biopolymer.
86. The method of claim 85, wherein the microdroplet further
comprises a catalyst.
87. The method of claim 84, wherein the microdroplet comprises a
solvent.
88. The method of claim 87, wherein the solvent has a boiling point
of 150.degree. C. or above, a surface tension of 30 dynes/cm or
above, and a viscosity of 0.015 g/(cm)(sec) or above.
89. The method of claim 88, wherein the solvent has the formula
(I): 11wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4 alkyl); Y=O,
S, N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and R=C.sub.1-C.sub.20
straight or branched chain alkyl.
90. The method of claim 89, wherein the solvent is selected from
the group consisting of: N-methyl-2-pyrrolidone; 2-pyrrolidone;
propylene carbonate; .gamma.-valerolactone; 6-caprolactam; ethylene
carbonate; .gamma.-butyrolactone; .delta.-valerolactone;
1,3-dimethyl-3,4,5,6-tetrah- ydro-2(1H)-pyrimidinone; ethylene
trithiocarbonate; and 1,3-dimethyl-2-imidazolidinone.
91. The method of claim 87, wherein said solvent is propylene
carbonate.
92. The method of claim 84, further comprising the steps of
repeating said steps (a)-(c).
93. The method of claim 85, further comprising the steps of
repeating said steps (a)-(c) to form a two-dimensional biopolymer
array.
94. The method of claim 84, wherein the biopolymer is an
oligonucleotide.
95. The method of claim 94, wherein the oligonucleotide is an
oligodeoxyribonucleotide or an oligoribonucleotide.
96. The method of claim 85, further comprising repeating said steps
(a)-(c) to form a two-dimensional oligonucleotide array.
97. The method of claim 84, wherein the step of aligning the
substrate comprises the steps of: (a) moving the substrate over a
marker to establish one or marks on the substrate; (b) subsequently
locating the marks with a camera; (c) determining misalignment of
the substrate relative to the print head with reference to the
marks; and (d) moving the substrate to correct the
misalignment.
98. The method of claim 97, wherein the step of moving the
substrate to correct the misalignment is done by moving the
substrate in a linear motion in X and Y directions and by rotating
the substrate.
99. A method of controlling a system synthesizing oligonucleotides
on a substrate using a computer having a memory for storing a
control program and data, wherein the system has an inkjet print
head for spraying a solution comprising a nucleoside or activated
nucleoside, on the substrate, a scanning transport for scanning the
substrate adjacent to the print head to selectively deposit the
solution, an alignment unit for detecting misalignment of the
substrate with respect to the print head at each deposition step, a
flow cell for treating the substrate, and a treating transport for
moving the substrate between the printer head and the flow cell,
the method comprising the steps of: (a) placing the substrate with
respect to the print head and establishing marks on the substrate;
(b) selectively depositing the solution on the substrate by sending
a signal to the print head to spray the solution and by sending a
signal to the scanning transport to move the substrate adjacent to
the print head so that the solution can be deposited at specified
loci on the substrate; (c) controlling treatment of the substrate
by sending a signal to the treating transport to move the substrate
to the flow cell and by sending a signal to the flow cell to
control operation of the flow cell; and (d) placing the substrate
adjacent to the print head and aligning the substrate with respect
to the print head by processing data from the alignment unit and by
sending a signal to the scanning transport to move the substrate so
as to correct misalignment of the substrate.
100. The method of claim 99, further comprising repeating said
steps (a)-(d) to form a two-dimensional oligonucleotide array.
101. A method for synthesizing an oligonucleotide, comprising the
steps of: (a) dispensing a first microdroplet of a solution
comprising (i) a first nucleoside having an activated O-succinate
group at its 3' position, and a protecting group at its 5' position
and (ii) a solvent having a boiling point of 150.degree. C. or
above, a surface tension of 30 dynes/cm or above, and a viscosity
of 0.015 g/(cm)(sec) or above, such that the microdroplet impinges
a substrate with a linker attached thereto having an amine group,
and forms a microdot upon the substrate; (b) rinsing the substrate
with a deprotecting agent which removes the protecting group from
the 5' position of the first nucleoside, and exposes a 5' hydroxyl
group; (c) dispensing a second microdroplet of a solution
comprising (i) a second nucleoside having a phosphoramidite group,
containing a cyanoethyl group, at its 3' position, and a protecting
group at its 5' position and (ii) the solvent, such that the second
microdroplet impinges the microdot; (d) dispensing a third
microdroplet of a solution comprising (i) a catalyst and (ii) the
solvent, such that the third microdroplet impinges the microdot and
facilitates a reaction between the phosphoramidite group of the
second nucleoside and the 5' hydroxyl group of the first
nucleoside, resulting in the conversion of the phosphoramidite
group to a phosphite group; (e) washing the substrate with an
oxidizing agent to convert the 3' phosphite group to a 3' phosphate
group; (f) performing successive iterations of steps (b)-(e); (g)
treating the product of step (f) with a second deprotecting agent
that converts the cyanoethylphosphate groups, of the product of
step (f), to phosphate groups; and (h) treating the product of step
(g) with a hydrolyzing agent which cleaves the oligonucleotide from
the linker.
102. The method of claim 101 wherein said solvent has the formula
(I): 12wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4 alkyl); Y=O,
S, N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and R=C.sub.1-C.sub.20
straight or branched chain alkyl.
103. The method of claim 101, wherein the solvent is selected from
the group consisting of: N-methyl-2-pyrrolidone; 2-pyrrolidone;
propylene carbonate; .gamma.-valerolactone; 6-caprolactam; ethylene
carbonate; .gamma.-butyrolactone; .delta.-valerolactone;
1,3-dimethyl-3,4,5,6-tetrah- ydro-2(1H)-pyrimidinone; ethylene
trithiocarbonate; and 1,3-dimethyl-2-imidazolidinone.
104. The method of claim 101, wherein said solvent is propylene
carbonate.
105. The method of claim 101, wherein the substrate is glass.
106. The method of claim 101, wherein the catalyst is
5-ethylthiotetrazole.
107. The method of claim 101, wherein the oxidizing agent is a
solution comprising iodine and water.
108. The method of claim 101, wherein the hydrolyzing agent is
selected from the group consisting of hydroxide ion,
CH.sub.3NH.sub.2 and concentrated aqueous NH.sub.4OH.
109. An automated system for synthesizing oligonucleotides on a
substrate, comprising: an inkjet print head having an array of
pumps for depositing a nucleoside or activated nucleoside at
specified loci on the substrate; a first translational stage having
at least two axes of movement; a first substrate chuck mounted for
movement by the translational stage, the first substrate chuck
being adapted to hold the substrate and move adjacent to the print
head; a flow cell that receives the substrate and that exposes the
substrate to one or more selected fluids; a second translational
stage that has at least two axes of movement; a second substrate
chuck mounted for movement by the second translation stage, the
second substrate chuck being adapted to hold the substrate and move
between the print head and the flow cell; control logic connected
to control movement of the first and second translational stages; a
marker positioned adjacent to the print head that can be activated
to mark particular loci on the substrate for positionally
calibrating the substrate with respect to the print head; and a
camera positioned adjacent to the print head to positionally
calibrate the substrate with respect to the print head, wherein the
camera is connected to provide images to the control logic.
110. The system of claim 109, wherein the first and the second
translational stages are driven by stepping motors.
111. The system of claim 109, wherein the first and second
substrate chucks are vacuum chucks.
112. The system of claim 109, wherein the first substrate chuck is
rotatable for alignment with the print head.
113. The system of claim 109, further comprising a tip that can be
activated to scratch marks at particular loci on the substrate for
positionally calibrating the substrate.
114. The system of claim 109, further comprising: a reservoir
connected to the print head to supply the nucleoside or activated
nucleoside to the print head, wherein the reservoir contains said
nucleoside or activated nucleoside dissolved in a solvent.
115. The system of claim 114, wherein the solvent has a boiling
point of 150.degree. C. or above, a surface tension of 30 dynes/cm
or above, and a viscosity of 0.015 g/(cm)(sec) or above.
116. The system of claim 115, wherein the solvent has the formula
(I): 13wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4 alkyl); Y=O,
S, N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and R=C.sub.2-C.sub.20
straight or branched chain alkyl.
117. The system of claim 116, wherein the solvent is selected from
the group consisting of: N-methyl-2-pyrrolidone; 2-pyrrolidone;
propylene carbonate; .gamma.-valerolactone; 6-caprolactam; ethylene
carbonate; .gamma.-butyrolactone; .delta.-valerolactone;
1,3-dimethyl-3,4,5,6-tetrah- ydro-2 (1H)-pyrimidinone; ethylene
trithiocarbonate; and 1,3-dimethyl-2-imidazolidinone.
118. The system of claim 115, wherein said solvent is propylene
carbonate.
119. A solution comprising a solvent and a nucleoside or activated
nucleoside, said solvent having a boiling point of 150.degree. C.
or above, a surface tension of 30 dynes/cm or above, and a
viscosity of 0.015 g/(cm)(sec) or above.
120. The solution of claim 119, wherein the solvent has the formula
(I): 14wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4 alkyl); Y=O,
S, N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and R=C.sub.2-C.sub.20
straight or branched chain alkyl.
121. The solution of claim 120, wherein the solvent is selected
from the group consisting of: N-methyl-2-pyrrolidone;
2-pyrrolidone; propylene carbonate; .gamma.-valerolactone;
6-caprolactam; ethylene carbonate; .gamma.-butyrolactone;
.delta.-valerolactone; 1,3-dimethyl-3,4,5,6-tetrah-
ydro-2(1H)-pyrimidinone; ethylene trithiocarbonate; and
1,3-dimethyl-2-imidazolidinone.
122. The solution of claim 119, wherein said solvent is propylene
carbonate.
123. The solution of claim 119, wherein the solution comprises an
activated nucleoside that contains an activated
phosphorous-containing group selected from the group consisting of
phosphodiester, phosphotriester, phosphate triester, H-phosphonate
and phosphoramidite group.
124. An apparatus programmed for controlling a system synthesizing
a biopolymer on a substrate, wherein the system has an inkjet print
head for spraying a microdroplet on the substrate, a scanning
transport for scanning the substrate adjacent to the print head to
selectively deposit the microdroplet, an alignment unit for
detecting misalignment of the substrate with respect to the print
head at each deposition step, a flow cell for treating the
substrate, and a treating transport for moving the substrate
between the printer head and the flow cell, the controller
comprising: (a) means for controlling alignment of the substrate
relative to the print head by processing data from the alignment
unit and by sending a signal to the scanning transport to move the
substrate so as to correct misalignment of the substrate; (b) means
for controlling selective deposition of a microdroplet on the
substrate by sending a signal to the print head to spray the
microdroplet and by sending a signal to the scanning transport to
move the substrate adjacent to the print head so that the
microdroplet can be deposited at specified loci on the substrate;
and (c) means for controlling treatment of the substrate by sending
a signal to the treating transport to move the substrate to the
flow cell and by sending a signal to the flow cell to control
operation of the flow cell.
125. The apparatus of claim 124, wherein the inkjet print head
contains a solution comprising a monomer unit of a biopolymer.
126. The apparatus of claim 125, wherein the solution further
comprises a catalyst.
127. The apparatus of claim 125, wherein the solution comprises a
solvent that has a boiling point of 150.degree. C. or above, a
surface tension of 30 dynes/cm or above, and a viscosity of 0.015
g/(cm)(sec) or above.
128. The apparatus of claim 127, wherein the solvent has the
formula (I): 15wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4
alkyl); Y=O, S, N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and
R=C.sub.1-C.sub.20 straight or branched chain alkyl.
129. The apparatus of claim 124, wherein the solvent is selected
from the group consisting of: N-methyl-2-pyrrolidone;
2-pyrrolidone; propylene carbonate; .gamma.-valerolactone;
6-caprolactam; ethylene carbonate; .gamma.-butyrolactone;
.delta.-valerolactone; 1,3-dimethyl-3,4,5,6-tetrah-
ydro-2(1H)-pyrimidinone; ethylene trithiocarbonate; and
1,3-dimethyl-2-imidazolidinone.
130. The apparatus of claim 127, wherein said solvent is propylene
carbonate.
131. An apparatus programmed for controlling a system synthesizing
a biopolymer on a substrate, wherein the system has an inkjet print
head for spraying a microdroplet on the substrate, a scanning
transport for scanning the substrate adjacent to the print head to
selectively deposit the microdroplet, an alignment unit for
detecting misalignment of the substrate with respect to the print
head at each deposition step, a flow cell for treating the
substrate, and a treating transport for moving the substrate
between the printer head and the flow cell, said apparatus
comprising one or more computer systems programmed for: (a)
controlling alignment of the substrate relative to the print head
by processing data from the alignment unit and by sending a signal
to the scanning transport to move the substrate so as to correct
misalignment of the substrate; (b) controlling selective deposition
of a microdroplet on the substrate by sending a signal to the print
head to spray the microdroplet and by sending a signal to the
scanning transport to move the substrate adjacent to the print head
so that the microdroplet can be deposited at specified loci on the
substrate; and (c) controlling treatment of the substrate by
sending a signal to the treating transport to move the substrate to
the flow cell and by sending a signal to the flow cell to control
operation of the flow cell.
132. The apparatus of claim 131, further comprising a reservoir
connected to the print head to suppy a nucleoside or activated
nucleoside to the print head, wherein the reservoir contains said
nucleoside or activated nucleoside dissolved in a solvent.
133. The apparatus of claim 131, wherein the inkjet print head
contains a solution comprising a monomer unit of a biopolymer.
134. The apparatus of claim 133, wherein the solution further
comprises a catalyst.
135. The apparatus of claim 133, wherein the solution comprises a
solvent that has a boiling point of 150.degree. C. or above, a
surface tension of 30 dynes/cm or above, and a viscosity of 0.015
g/(cm)(sec) or above.
136. The apparatus of claim 135, wherein the solvent has the
formula (I): 16wherein A=O or S; X=O, S or N(C.sub.1-C.sub.4
alkyl); Y=O, S, N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and
R=C.sub.1-C.sub.20 straight or branched chain alkyl.
137. The apparatus of claim 136, wherein the solvent is selected
from the group consisting of: N-methyl-2-pyrrolidone;
2-pyrrolidone; propylene carbonate; .gamma.-valerolactone;
6-caprolactam; ethylene carbonate; .gamma.-butyrolactone;
.delta.-valerolactone; 1,3-dimethyl-3,4,5,6-tetrah-
ydro-2(1H)-pyrimidinone; ethylene trithiocarbonate; and
1,3-dimethyl-2-imidazolidinone.
138. The apparatus of claim 135, wherein said solvent is propylene
carbonate.
139. An inkjet print head containing the solution of claim 119.
140. An inkjet print head containing the solution of claim 120.
141. An inkjet print head containing the solution of claim 121.
142. An inkjet print head containing the solution of claim 122.
143. A method for synthesizing an oligonucleotide, comprising the
steps of: (a) dispensing a first microdroplet of a solution
comprising (i) a first nucleoside having a phosphoramidite group at
its 5' position, and a protecting group at its 3' position and (ii)
a solvent having a boiling point of 150.degree. C. or above, a
surface tension of 30 dynes/cm or above, and a viscosity of 0.015
g/(cm)(sec) or above, such that the microdroplet impinges a
substrate with a linker attached thereto having hydroxyl groups,
and forms a microdot upon the substrate; (b) dispensing a second
microdroplet of a solution comprising (i) a catalyst and (ii) the
solvent, such that the second microdroplet impinges the microdot
and facilitates a reaction between the phosphoramidite group of the
first nucleoside and an hydroxyl group of the linker, resulting in
the conversion of the phosphoramidite group to a 5' phosphite
group, and the presence of unreacted hydroxyl groups of the linker;
(c) washing the substrate with an oxidizing agent to convert the 5'
phosphite group to a 5' phosphate group; (d) rinsing the substrate
with a deprotecting agent which removes the protecting group from
the 3' position of the first nucleoside, and yields a 3' hydroxyl
group; (e) dispensing a third microdroplet of a solution comprising
(i) a second nucleoside having a phosphoramidite group at its 5'
position, and a protecting group at its 3' position and (ii) the
solvent, such that the second microdroplet impinges the microdot;
and (f) dispensing a fourth microdroplet of a solution comprising
(i) the catalyst and (ii) the solvent, such that the fourth
microdroplet impinges the microdot and facilitates a reaction
between the phosphoramidite group of the second nucleoside and the
3' hydroxyl group of the first nucleoside, resulting in the
coupling of the second nucleoside to the first nucleoside.
144. The method of claim 143, further comprising after step (c) and
before step (d) the step of treating the substrate with a capping
reagent which caps the unreacted hydroxyl groups of the linker.
145. The method of claim 144, wherein the capping reagent is
perfluorooctanoyl chloride.
146. A method for synthesizing an oligonucleotide, comprising the
steps of: (a) dispensing a first microdroplet of a solution
comprising (i) a first nucleoside having an activated O-succinate
group at its 5' position, and a protecting group at its 3' position
and (ii) a solvent having a boiling point of 150.degree. C. or
above, a surface tension of 30 dynes/cm or above, and a viscosity
of 0.015 g/(cm)(sec) or above, such that the microdroplet impinges
a substrate with a linker attached thereto having an amine group,
and forms a microdot upon the substrate; (b) rinsing the substrate
with a deprotecting agent which removes the protecting group from
the 3' position of the first nucleoside, and exposes a 3' hydroxyl
group; (c) dispensing a second microdroplet of a solution
comprising (i) a second nucleoside having a phosphoramidite group
containing a cyanoethyl group, at its 5' position, and a protecting
group at its 3' position and (ii) the solvent, such that the second
microdroplet impinges the microdot; (d) dispensing a third
microdroplet of a solution comprising (i) a catalyst and (ii) the
solvent, such that the third microdroplet impinges the microdot and
facilitates a reaction between the phosphoramidite group of the
second nucleoside and the 3' hydroxyl group of the first
nucleoside, resulting in the conversion of the phosphoramidite
group to a phosphite group; (e) washing the substrate with an
oxidizing agent to convert the 5' phosphite group to a 5' phosphate
group; (f) performing successive iterations of steps (b)-(d); (g)
treating the product of step (f) with a second deprotecting agent
that converts the cyanoethyl groups, of the product of step (f), to
phosphate groups; and (h) treating the product of step (g) with a
hydrolyzing agent which cleaves the oligonucleotide from the
linker.
147. A method for synthesizing an oligonucleotide, comprising the
steps of: (a) dispensing a first microdroplet of a solution
comprising (i) a first nucleoside having a phosphoramidite group at
its 3' position, and a protecting group at its 5' position and (ii)
a solvent having a boiling point of 150.degree. C. or above, a
surface tension of 30 dynes/cm or above, and a viscosity of 0.015
g/(cm)(sec) or above, such that the microdroplet impinges a
substrate with a linker attached thereto having hydroxyl groups,
and forms a microdot upon the substrate; (b) dispensing a second
microdroplet of a solution comprising (i) a catalyst and (ii) the
solvent, such that the second microdroplet impinges the microdot
and facilitates a reaction between the phosphoramidite group of the
first nucleoside and an hydroxyl group of the linker, resulting in
the conversion of the phosphoramidite group to a 3' phosphite
group, and the presence of unreacted hydroxyl groups of the linker;
(c) washing the substrate with an oxidizing agent to convert the 3'
phosphite group to a 3' phosphate group; (d) rinsing the substrate
with a deprotecting agent which removes the protecting group from
the 5' position of the first nucleoside, and yields a 5' hydroxyl
group; (e) dispensing a third microdroplet of a solution comprising
(i) a second nucleoside having a phosphoramidite group at its 5'
position, and a protecting group at its 3' position and (ii) the
solvent, such that the second microdroplet impinges the microdot;
and (f) dispensing a fourth microdroplet of a solution comprising
(i) the catalyst and (ii) the solvent, such that the fourth
microdroplet impinges the microdot and facilitates a reaction
between the phosphoramidite group of the second nucleoside and the
5' hydroxyl group of the first nucleoside, resulting in the
coupling of the second nucleoside to the first nucleoside.
148. The method of claim 147, further comprising after step (c) and
before step (d) the step of treating the substrate with a capping
reagent which caps the unreacted hydroxyl groups of the linker.
149. The method of claim 148, wherein the capping reagent is
perfluorooctanoyl chloride.
150. A method for synthesizing an oligonucleotide, comprising the
steps of: (a) dispensing a first microdroplet of a solution
comprising (i) a first nucleoside having a phosphoramidite group at
its 5' position, and a protecting group at its 3' position and (ii)
a solvent having a boiling point of 150.degree. C. or above, a
surface tension of 30 dynes/cm or above, and a viscosity of 0.015
g/(cm)(sec) or above, such that the microdroplet impinges a
substrate with a linker attached thereto having hydroxyl groups,
and forms a microdot upon the substrate; (b) dispensing a second
microdroplet of a solution comprising (i) a catalyst and (ii) the
solvent, such that the second microdroplet impinges the microdot
and facilitates a reaction between the phosphoramidite group of the
first nucleoside and an hydroxyl group of the linker, resulting in
the conversion of the phosphoramidite group to a 5' phosphite
group, and the presence of unreacted hydroxyl groups of the linker;
(c) washing the substrate with an oxidizing agent to convert the 5'
phosphite group to a 5' phosphate group; (d) rinsing the substrate
with a deprotecting agent which removes the protecting group from
the 3' position of the first nucleoside, and yields a 3' hydroxyl
group; (e) dispensing a third microdroplet of a solution comprising
(i) a second nucleoside having a phosphoramidite group at its 3'
position, and a protecting group at its 5' position and (ii) the
solvent, such that the second microdroplet impinges the microdot;
and (f) dispensing a fourth microdroplet of a solution comprising
(i) the catalyst and (ii) the solvent, such that the fourth
microdroplet impinges the microdot and facilitates a reaction
between the phosphoramidite group of the second nucleoside and the
3' hydroxyl group of the first nucleoside, resulting in the
coupling of the second nucleoside to the first nucleoside.
151. The method of claim 150, further comprising after step (c) and
before step (d) the step of treating the substrate with a capping
reagent which caps the unreacted hydroxyl groups of the linker.
152. The method of claim 151, wherein the capping reagent is
perfluorooctanoyl chloride.
153. A method for synthesizing an oligonucleotide, comprising the
steps of: (a) dispensing a first microdroplet of a solution
comprising (i) a first nucleoside having an activated O-succinate
group at its 5' position, and a protecting group at its 3' position
and (ii) a solvent having a boiling point of 150.degree. C. or
above, a surface tension of 30 dynes/cm or above, and a viscosity
of 0.015 g/(cm)(sec) or above, such that the microdroplet impinges
a substrate with a linker attached thereto having an amine group,
and forms a microdot upon the substrate; (b) rinsing the substrate
with a deprotecting agent which removes the protecting group from
the 3' position of the first nucleoside, and exposes a 3' hydroxyl
group; (c) dispensing a second microdroplet of a solution
comprising (i) a second nucleoside having a phosphoramidite group
containing a cyanoethyl group, at its 3' position, and a protecting
group at its 5' position and (ii) the solvent, such that the second
microdroplet impinges the microdot; (d) dispensing a third
microdroplet of a solution comprising (i) a catalyst and (ii) the
solvent, such that the third microdroplet impinges the microdot and
facilitates a reaction between the phosphoramidite group of the
second nucleoside and the 3' hydroxyl group of the first
nucleoside, resulting in the conversion of the phosphoramidite
group to a phosphite group; (e) washing the substrate with an
oxidizing agent to convert the 5' phosphite group to a 5' phosphate
group; (f) performing successive iterations of steps (b)-(d); (g)
treating the product of step (f) with a second deprotecting agent
that converts the cyanoethyl groups, of the product of step (f), to
phosphate groups; and (h) treating the product of step (g) with a
hydrolyzing agent which cleaves the oligonucleotide from the
linker.
154. A method for synthesizing an oligonucleotide, comprising the
steps of: (a) dispensing a first microdroplet of a solution
comprising (i) a first nucleoside having an activated O-succinate
group at its 3' position, and a protecting group at its 5' position
and (ii) a solvent having a boiling point of 150.degree. C. or
above, a surface tension of 30 dynes/cm or above, and a viscosity
of 0.015 g/(cm)(sec) or above, such that the microdroplet impinges
a substrate with a linker attached thereto having an amine group,
and forms a microdot upon the substrate; (b) rinsing the substrate
with a deprotecting agent which removes the protecting group from
the 5' position of the first nucleoside, and exposes a 5' hydroxyl
group; (c) dispensing a second microdroplet of a solution
comprising (i) a second nucleoside having a phosphoramidite group,
having a cyanoethyl group, at its 5' position, and a protecting
group at its 3' position and (ii) the solvent, such that the second
microdroplet impinges the microdot; (d) dispensing a third
microdroplet of a solution comprising (i) a catalyst and (ii) the
solvent, such that the third microdroplet impinges the microdot and
facilitates a reaction between the phosphoramidite group of the
second nucleoside and the 5' hydroxyl group of the first
nucleoside, resulting in the conversion of the phosphoramidite
group to a phosphite group; (e) washing the substrate with an
oxidizing agent to convert the 3' phosphite group to a 3' phosphate
group; (f) performing successive iterations of steps (b)-(d); (g)
treating the product of step (f) with a second deprotecting agent
that converts the cyanoethylphosphate groups, of the product of
step (f), to phosphate groups; and (h) treating the product of step
(g) with a hydrolyzing agent which cleaves the oligonucleotide from
the linker.
155. The method of any one of claims 143, 146, 147, 150, 153, or
154, wherein said solvent has the formula (I): 17wherein A=O or S;
X=O, S or N(C.sub.1-C.sub.4 alkyl); Y=O, S, N(C.sub.1-C.sub.4
alkyl) or CH.sub.2; and R=C.sub.1-C.sub.20 straight or branched
chain alkyl.
Description
FIELD OF THE INVENTION
[0002] The present invention relates to chemical synthesis,
particularly synthesis of biopolymers such as oligonucleotides and
peptides, using solvent microdroplets as a means for reagent
delivery.
BACKGROUND OF THE INVENTION
[0003] Genetic information generated by the Human Genome Project is
allowing scientists, physicians, and others to conduct diagnostic
and experimental procedures on an unprecedented scale in terms of
speed, efficiency, and number of screenings performed within one
procedure. In order to make full use of this new information, there
is an urgent need for the ability to screen a large number of
chemical compounds, particularly oligonucleotide probes, against
samples of DNA or RNA from normal or diseased cells and tissue. One
important tool for such analyses is nucleic acid hybridization,
which relies on the difference in interaction energies between
complementary and mismatched nucleic acid strands (see U.S. Pat.
No. 5,552,270 to Khrapko et al.). Using this tool, it is possible
to determine whether two short pieces of nucleic acid are exactly
complementary. Longer nucleic acids can also be compared for
similarity.
[0004] Nucleic acid hybridization is often used for screening
cloned libraries to identify similar, and thus presumably related,
clones. This procedure typically involves using (a) natural nucleic
acid targets which are usually bound to a membrane, and (b) a
natural or synthetic nucleic acid probe which is washed over many
targets at once. With the appropriate mechanics, membranes can be
constructed with targets at a density of generally between one and
ten targets per mm.sup.2. Hybridization detection is carried out by
labeling the probe, for example either radioactively or with
chemiluminescent reagents, and then recording the probe's emissions
onto film.
[0005] Alternative approaches to nucleic acid hybridization have
involved oligonucleotide probes that are synthesized on a solid
support or a substrate, and then hybridized to a single natural
target. Solid phase synthesis techniques for obtaining peptides (K.
S. Lam et al., Nature 354:82 (1991) and Geysen et al., J. Immunol.
Methods 102:259 (1987)) and oligonucleotides (J. Weiler et al.,
Anal. Biochem. 243:218 (1996) and U. Maskos et al., Nucleic Acids
Res. 20(7):1679 (1992); T. Atkinson et al., Solid-Phase Synthesis
of Oligodeoxyribonucleotides by the Phosphitetriester Method, in
Oligonucleotide Synthesis 35 (M. J. Gait ed., 1984) have been
disclosed. While such approaches have the potential for large-scale
assembly of oligonucleotide arrays, the cost of making such a
variety of arrays is prohibitive.
[0006] Recently, there have been reports of using microdrop
dispensers to generate oligomers and polymers arranged, on a
substrate, in arrays of microdroplets:
[0007] 1. T. Brennan, Human Genome Program, U.S. Department of
Energy, Contractor-Grantee Workshop III, February 7-10, 1993, Santa
Fe, N. Mex., Methods to Generate Large Arrays of Oligonucleotides
92 (1993), discloses that arrays of oligonucleotides were sought to
be synthesized in parallel chemical reactions on glass plates,
using arrays of piezoelectric pumps, similar to an inkjet printer,
as a means for delivering reagents. In such a scheme, each array
element is separated by its neighbor by a perfluoroalkane tension
barrier which is not wet by the acetonitrile reaction solvent.
[0008] 2. U.S. Pat. No. 5,449,754 to Nishioka discloses that
peptide arrays can be obtained using an inkjet print head to
deposit a dimethylformamide solution of N-protected activated amino
acids, in the form of microdroplets, onto an aminosilylated glass
slide which is subsequently washed with a trifluoroacetic acid
solution to remove the N-protecting groups from the anchored amino
acids. The process is repeated until amino acids having the desired
sequence are obtained.
[0009] 3. U.S. Pat. No. 5,474,796 to Brennan describes a
piezoelectric impulse jet pump apparatus for synthesizing arrays of
oligomers or polymers having subunits connected by ester or amide
bonds. According to that scheme, a glass plate is coated with a
fluoropolymer which is then selectively removed, leaving glass
regions, in spots upon which oligomer or polymer synthesis would
take place. The glass regions are epoxidized and subsequently
hydrolyzed to afford a hydroxyalkyl group that would react with an
activated chemical species. Where the oligomers sought to be
synthesized are oligonucleotides, microdroplets of acetonitrile or
diethyleneglycol dimethyl ether solutions of 5'-protected
nucleotide monomers that are activated at their 3'-positions would
be dispensed via a piezoelectric jet head, and would impinge upon
the hydroxyalkyl group, forming a covalent bond therewith. After
removing the 5'-protecting groups by flooding the surface of the
plate with a deprotecting reagent, the process is repeated until
the desired oligonucleotides are obtained.
[0010] 4. International Publication No. WO 95/25116 by
Baldeschwieler et al. discloses a method for chemical synthesis at
different sites on a substrate using an inkjet printing device to
deliver reagents to specific sites of the substrate. In that
instance, the inkjet printing device would deposit, in sequence,
(a) a protected molecule onto the substrate, (b) a deprotecting
reagent onto the protected molecule so as to expose a reactive
site, and (c) a second protected molecule at the site of the
now-deprotected molecule, so as to form a growing chain of
molecules. The entire process is repeated as necessary. According
to this publication by Baldeschwieler et al., useful reaction
solvents are dibromomethane, nitromethane, acetonitrile and
dimethylformamide.
[0011] 5. U.S. Pat. No. 5,658,802 to Hayes et al. discloses a
dispensing apparatus that is allegedly capable of providing
droplets having a volume of 10 pL to 100 pL, and purportedly useful
for synthesizing arrays of diagnostic probes. According to that
reference, the dispensing apparatus is capable of dispensing
"liquids" that may contain DNA molecules, peptides, antibodies,
antigens, enzymes or entire cells; however, no specific examples of
such "liquids" are disclosed.
[0012] There exists a need for a method of efficiently synthesizing
chemical compounds on a large scale that can be automated. Prior
art suggestions for achieving such involve various drawbacks.
[0013] The present inventor has realized the nature of these
drawbacks, which is overcome by the present invention. In
particular, the dispensation of certain organic solvents from an
inkjet printing device for use in chemical synthesis has several
drawbacks. First, many organic solvents, such as alcohols or
amines, bear functional groups that are capable of reacting with
those chemical compounds sought to be dispensed from the inkjet
device. Second, solvents having boiling points of less than
150.degree. C. are relatively volatile, and can evaporate from a
substrate before the reactant(s) dissolved therein have completely
reacted with any species bound to the substrate. Third, such
volatile solvents can begin to evaporate at the site of the inkjet
print head, causing reactants dissolved in the solvents to
precipitate and clog the inkjet nozzle. Fourth, solvents that have
surface tension values that are lower than 30 dynes/cm at room
temperature have a relatively high affinity for the face of the
inkjet nozzle, and tend to give rise to unstable and non-uniformly
sized droplets. Fifth, solvents that have viscosity values that are
lower than 1 centipoise at room temperature tend to form
non-uniformly sized droplets due to their response to residual
oscillations in the solvent. Sixth, many organic solvents,
particularly acetonitrile, have the highly undesirable
characteristic of being capable of dissolving adhesives and
plastics used in inkjet print heads. Thus, prior to the present
invention the organic solvents used for synthesizing
oligonucleotides were ineffective in automated systems employing
plastic components such as ink jet print heads.
[0014] Thus, there exists a need for a class of organic solvents,
useful for chemical synthesis, that is relatively inert, and that
has boiling point, surface tension and viscosity properties that
are optimal for microdroplet formation from an inkjet device. Such
a need is satisfied by the present invention.
[0015] The use of inkjet printing technology in chemical synthesis
would be particularly useful for a large-scale synthesis of
biopolymers, such as oligonucleotides. While a manual approach
might improve the efficiency of large-scale synthesis to some
degree, manual steps would be time-consuming. Specifically, a
rinsing step would be performed after each deposition step to rinse
away the unattached monomers, which would be time-consuming if done
manually.
[0016] The present inventor has also appreciated that in order to
alternate efficiently between the deposition step and the rinsing
step, a system may be designed in such a way that the substrate is
made to move while the print heads remain stationary, depositing
microdroplets of nucleoside monomers. However, each time the
substrate is positioned for deposition, the substrate must be
aligned correctly relative to the print heads to ensure that the
monomers can be deposited at precise locations on the substrate.
This is a time-consuming process if it is to be done manually.
[0017] Thus, there exists a need for an automated system for
efficiently performing large-scale synthesis of biopolymers using
inkjet printing technology and particularly a need for an automated
alignment mechanism which can be used to position the substrate
precisely with respect to the print heads without manual
intervention. Such a need is satisfied by the present
invention.
[0018] Citation of any references above shall not be construed as
an admission that such reference is available as prior art to the
present application.
SUMMARY OF THE INVENTION
[0019] The present invention relates to a microdroplet of a
solution, the solution comprising a solvent having a boiling point
of 150.degree. C. or above, a surface tension of 30 dynes/cm or
above, and a viscosity of 0.015 g/(cm)(sec) or above.
[0020] The invention further provides a method for dispensing
microdroplets of a solution from a microdroplet dispensing device,
the microdroplet dispensing device comprising (a) a manifold which
contains the solution, (b) a nozzle at one end of the manifold and
(c) means for applying a pressure pulse to the manifold, the means
located at the other end of the manifold, comprising the step of
applying a pressure pulse to the manifold, thereby dispensing the
solution through the nozzle in microdroplet form, the solution
comprising a solvent having a boiling point of 150.degree. C. or
above, a surface tension of 30 dynes/cm or above, and a viscosity
of 0.015 g/(cm)(sec) or above.
[0021] The invention still further provides a method for chemical
synthesis, comprising the step of dispensing a microdroplet of a
solution comprising (i) a first chemical species and (ii) a
solvent, such that the microdroplet impinges a second chemical
species and forms a third chemical species therewith, the solvent
having a boiling point of 150.degree. C. or above, a surface
tension of 30 dynes/cm or above, and a viscosity of 0.015
g/(cm)(sec) or above.
[0022] The invention also provides a fully automated solution for
synthesizing oligonucleotides, particularly deoxyribonucleosides
and ribonucleosides, by repeatedly cycling a substrate through
steps of depositing nucleoside monomers and of treating the
substrate by rinsing off unattached nucleoside monomers. A system
in accordance with the invention includes an inkjet print head for
spraying nucleoside monomers on a substrate, a scanning transport
for moving the substrate with respect to the print head so that the
monomer is deposited at specified sites, a flow cell for treating
the substrate deposited with the monomer by exposing the substrate
to selected fluids, a treating transport for moving the substrate
between the print head and the flow cell for treatment in the flow
cell, and an alignment unit for aligning the substrate so that the
substrate is correctly positioned with respect to the print head
each time the substrate is positioned for deposition.
Computer-controlled motion stages and vacuum chucks are used to
move the substrate during deposition and to move the substrate
between the print head and the flow cell.
[0023] Each time the substrate is picked up by a vacuum chuck and
placed over the print head, the substrate is positionally
calibrated by using a camera in conjunction with marks that are
placed on the substrate the first time it is handled. Translational
misalignment is corrected by moving the vacuum chuck in two axes of
linear motion. Rotational misalignment is corrected by physically
rotating the vacuum chuck within a substrate holder.
[0024] Software, programmed apparatuses, and computer readable
memory, for carrying out the methods of the invention are also
provided.
[0025] The present invention may be understood more fully by
reference to the following figures, detailed description and
illustrative examples which are intended to exemplify non-limiting
embodiments of the invention.
BRIEF DESCRIPTION OF THE DRAWINGS
[0026] FIG. 1a is a copy of a photograph of water condensed onto an
array of approximately 250 surface tension wells. Individual
droplets are confined to square regions of 100 micron sides by 30
micron wide hydrophobic barriers.
[0027] FIG. 1b is a side view of a surface tension well showing the
arrangement of hydrophilic and hydrophobic regions, and a cross
section of a reagent drop sitting on an hydroxylated hydrophilic
surface. The bottom layer substrate is silicon dioxide, and
repeating units of --F represent a perfluorinated hydrophobic
surface. The reagent drop sits on repeating --OH units of the
silicon dioxide support. The diameter of the reagent drop is
approximately 100 .mu.m.
[0028] FIG. 2 is a schematic diagram of a piezoelectric pump in an
inkjet print head.
[0029] FIG. 3 shows the substrate with surface tension wells, moved
by an X-Y translation stage, above the nozzles spraying
microdroplets.
[0030] FIG. 4 is a scheme showing a complete cycle of
oligonucleotide synthesis comprising (a) delivering a reactant to
each well, (b) washing away unreacted monomers, and (c)
deprotecting the ends of the extended molecules.
[0031] FIG. 5 shows an automated system for synthesizing
oligonucleotides in accordance with the invention.
[0032] FIG. 6 shows inkjet print heads used in the system of FIG.
5.
[0033] FIG. 7 shows a scanning transport used in the system of FIG.
5.
[0034] FIG. 8 shows an alignment unit used in the system of FIG.
5.
[0035] FIG. 9 shows a flow cell used in the system of FIG. 5.
[0036] FIG. 10 shows a transfer station used in the system of FIG.
5.
[0037] FIG. 11 is a block diagram showing a computer and control
components used in conjunction with the system of FIG. 5.
[0038] FIG. 12 is a block diagram of a controller used to control
the inkjet print heads.
[0039] FIG. 13 is a flow chart depicting the operation of the
computer software used to initialize the inkjet print heads.
[0040] FIG. 14 is a flow chart depicting the operation of the
software used to control the operation of the automated synthesis
system.
[0041] FIG. 15 is a flow chart depicting the operation of the
software used to control the operation of the scanning transport
and the operation of the flow cell.
[0042] FIG. 16 is a flow chart depicting the operation of the
software used to align a substrate relative to the print heads.
[0043] FIG. 17 is a flow chart depicting the operation of the
software used to further align the substrate.
[0044] FIG. 18 is a flow chart depicting the operation of the
software used to further control the operation of the flow
cell.
[0045] FIG. 19 is a flow chart depicting the operation of the
software used to measure the center positions of registration marks
used for alignment.
[0046] FIG. 20 is a flow chart depicting the operation of the
software used to calculate the slope and equation of a line
detected by a camera during alignment.
[0047] FIG. 21 is a flow chart depicting the operation of the
software used control the deposition of a layer of nucleoside
monomers.
DETAILED DESCRIPTION OF CHEMICAL SYNTHESIS USING MICRODROPLETS
MICRODROPLETS
[0048] The present invention relates to a microdroplet of a
solution, the solution comprising a high surface tension solvent
having a boiling point of about 150.degree. C. or above, a surface
tension of about 30 dynes/cm or above, and a viscosity of about
0.015 g/(cm)(sec) or above. Each microdroplet is a separate and
discrete unit, preferably having a volume of about 100 pL or less,
more preferably about 50 pL or less. Such microdroplets are useful
for synthesis of chemical compounds, and in particular, for the
synthesis of arrays of chemical compounds that are arranged in
microdots which are separate and discrete units. It will be
understood by those skilled in the art that a "solution" comprises
"solvent" and "solute". In the present instance, the "solute" is
preferably a chemical species that is a reagent, as described
below. As used herein, "microdot" refers to a microdroplet that is
associated with a substrate.
[0049] The arrays of chemical compounds synthesized by the methods
of the invention are useful as libraries of chemical probes. Where
the different chemical compounds obtained by the methods of the
present invention are peptides, the peptide arrays can be contacted
with a protein or peptide of known sequence, such as an antibody, a
cell receptor or other type of receptor, so as to identify a
peptide, synthesized according to the present invention, that is
capable of binding to the peptide of known sequence. Such a peptide
can be readily sequenced by methods well known to those skilled in
the art. Where the different chemical compounds synthesized by the
present invention are oligonucleotides, the oligonucleotide arrays
can be used as hybridization probes, for example, for genotyping or
expression analysis, e.g., as a tool in gene therapy whereby
mutations may be identified in a genome, or to identify DNA in
samples from the environment, or may be used to synthesize
complementary oligonucleotides by using DNA polymerase and primers,
or as primers for DNA sequencing or polymerase chain reaction.
Where the different chemical compounds synthesized by the present
invention are peptides, oligonucleotides, or other chemical species
such as polysaccharides or other biologically active molecules,
such chemical species can be subjected to a variety of drug
screening assays to identify and ascertain their efficacy.
[0050] As stated above, the microdroplets of the present invention
are in the form of separate and discrete units. By this is meant
that the microdroplets that comprise the first chemical species do
not intermix prior to impinging those microdots that comprise the
second chemical species. As also stated above, the arrays of
compounds that are obtained in accordance with the present
invention are arranged in microdots which are separate and discrete
units. By this is meant that each microdroplet that impinges a
second chemical species is delivered such that the resulting
microdots which each comprise a third chemical species do not
overlap or intermingle. It is to be pointed out, however, that the
second chemical species need not be arranged in separate and
discrete units prior to reaction with the first chemical species;
for example, a substrate having a plurality of functional groups
that are not set apart from each other in separate domains can be
impinged by microdroplets at separate and discrete loci, resulting
in the formation of separate and discrete microdots of a third
chemical species which are separated from each other via the
unreacted second chemical species.
SOLVENTS FOR MICRODROPLETS
[0051] The present inventor has found, surprisingly and
unexpectedly, that high surface tension solvents that have a
boiling point of 150.degree. C. or above, a surface tension of 30
dynes/cm or above, and a viscosity of 0.015 g/(cm)(sec) or above,
give rise to microdroplets that have properties that are optimal
for microdroplet formation and stability, particularly when used as
a reaction solvent for the synthesis of arrays of organic compounds
such as oligonucleotides and peptides. It is to be pointed out that
the boiling point, surface tension and viscosity values of the
present solvents are those obtained when measured at or around 760
mm/Hg, and at or around room temperature (approximately 22.degree.
C.).
[0052] For example, the present microdroplets, which comprise
solvents that have boiling points of 150.degree. C. or above, or
thereabout, overcome the disadvantages of those microdroplets that
comprise lower boiling solvents by not readily evaporating upon
formation or deposition. This characteristic is especially
important when the microdroplets are to be used as vehicles for
chemical reagents: where a reactive chemical species contained in
one microdroplet seeks to react with a reactive chemical species
contained in a second microdroplet that is impinged by the first,
the use of relatively high boiling solvent, as in present
microdroplets, ensures that the solvent does not evaporate prior to
reaction between the two reactive chemical species. In addition,
microdroplets that are formed from solvents that have boiling
points of 150.degree. C. or above do not appreciably evaporate upon
formation, which prevents (a) deposition of microdroplet solutes
around or within the microdroplet generating source, and
accordingly prevents clogging; and (b) unwanted precipitation of
solutes onto the array surface.
[0053] It has also been found that microdroplets, particularly
those having a volume of about 100 pL or less, that comprise
solvents that have surface tensions of 30 dynes/cm or above, or
thereabout, have a relatively low affinity for the face of a nozzle
used to generate microdroplets and accordingly, are more stable and
uniformly sized. These properties are particularly desirable when
the amount of solute, e.g., a reactive chemical species, that is to
be dispensed as a microdroplet solution, should preferably be
uniform from microdroplet to microdroplet, such as for example in
the case of organic synthesis. In addition, microdroplets that have
a relatively low affinity for the face of a nozzle can be dispensed
more efficiently than those that have a relatively high affinity
for the face of a nozzle.
[0054] It has further been found that microdroplets, particularly
those having a volume of about 100 pL or less, that comprise
solvents that have viscosity values of 0.015 g/(cm)(sec) or above,
or thereabout, do not succumb to residual oscillations caused by
the microdroplet generating device and accordingly, maintain their
structural integrity, e.g., spherical shape, when dispensed. This
property is particularly important when the dispensed microdroplets
are to be deposited in closely packed arrays of uniformly shaped
microdots that cannot overlap.
[0055] In addition, solvents that have the above boiling point,
surface tension and viscosity properties do not appreciably
initiate the degradation or decomposition of synthetic polymers
that are commonly used in microdroplet dispensing devices, allowing
them to be used in conjunction with a variety of plastic parts or
components.
[0056] Furthermore, where the solvent is to be used for organic
synthesis, the solvent molecules must not comprise, or must not be
modified so as to comprise, reactive functional groups, such as
hydroxyl, primary amino, secondary amino, sulfhydryl, carboxyl, and
anhydride groups, that can easily interfere, i.e., react, with a
starting material, reagent, intermediate or product chemical
species.
[0057] The present inventor has found that a class of organic
solvents that (a) has (i) a boiling point of 150.degree. C. or
above, (ii) a surface tension of 30 dynes/cm or above, and (iii) a
viscosity of 0.015 g/(cm)(sec); and (b) is represented by the
formula (I): 2
[0058] wherein
[0059] A=O or S;
[0060] X=O, S or N(C.sub.1-C.sub.4 alkyl);
[0061] Y=O, S, N(C.sub.1-C.sub.4 alkyl) or CH.sub.2; and
[0062] R=C.sub.1-C.sub.20 straight or branched chain alkyl, is
particularly preferred for use in chemical synthesis where a first
chemical species is delivered to a second chemical species in the
form of a microdroplet.
[0063] As used herein, "branched chain alkyl" refers to a
C.sub.1-C.sub.19 straight chain alkyl group substituted with one or
more methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl,
sec-butyl, tert-butyl, n-pentyl, (1-methyl)butyl, (2-methyl)butyl,
(3-methyl)butyl and neopentyl groups, or the like; wherein the
total number of carbon atoms of the branched chain alkyl does not
exceed twenty.
[0064] Preferably, --R-- is a branched chain alkyl, and has the
formula --CH(CH.sub.3)--, --CH.sub.2CH.sub.2--,
--CH(CH(CH.sub.3).sub.2)--, --CH(CH(CH.sub.3))CH-- or
--CH.sub.2CH(CH.sub.3)--. Especially preferred solvents of formula
(I) include, but are not limited to:
[0065] N-methyl-2-pyrrolidone (boiling point=202.degree. C.;
surface tension=40.7 dynes/cm; and viscosity=0.017
g/(cm)(sec));
[0066] 2-pyrrolidone (boiling point=245.degree. C.; surface
tension=46.9 dynes/cm; and viscosity=0.13 g/(cm)(sec));
[0067] propylene carbonate (boiling point=240.degree. C.; surface
tension=40.7 dynes/cm; and viscosity=0.025 g/(cm)(sec));
[0068] .gamma.-valerolactone (boiling point=208.degree. C.; surface
tension=30.9 dynes/cm (at 51.degree. C.); and viscosity=0.033
g/(cm)(sec));
[0069] 6-caprolactam (boiling point=270.degree. C.; surface
tension=42 dynes/cm (at 69.degree. C.); and viscosity=0.12
g/(cm)(sec) (at 70.degree. C.));
[0070] ethylene carbonate (boiling point=248.degree. C.; surface
tension=42.6 dynes/cm (at 37.degree. C.); and viscosity= 0.012
g/(cm)(sec) (at 38.degree. C.));
[0071] .gamma.-butyrolactone (boiling point=206.degree. C.; surface
tension=36.5 dynes/cm (at 43.degree. C.); and viscosity=0.017
g/(cm) (sec));
[0072] .delta.-valerolactone (boiling point=218-220.degree. C.;
surface tension and viscosity values not available);
[0073] 1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone (boiling
point=230.degree. C. (754 mm/Hg); surface tension=36.12 dynes/cm;
and viscosity=0.029 g/(cm)(sec));
[0074] ethylene trithiocarbonate (boiling point= 307.degree. C.;
surface tension and viscosity values not available); and
[0075] 1,3-dimethyl-2-imidazolidinone (boiling point= 220.degree.
C. (754 mm/Hg; surface tension=37.6 dynes/cm; and viscosity=0.019
g/(cm)(sec)).
[0076] Propylene carbonate solvent is most preferred.
[0077] It is to be pointed out that boiling point values increase
as the pressure increases, and surface tension and viscosity values
increase as the temperature decreases. Accordingly, the boiling
point values are higher at 760 mm/Hg than at certain lower
pressures reported above, and the surface tension and viscosity
values are higher at room temperature than at certain higher
temperatures reported above.
[0078] It is also to be pointed out that the solvents of the
invention do not necessarily have to exhibit all three
characteristics of having a boiling point of about 150.degree. C.
or above, a surface tension of about 30 dynes/cm or above, and a
viscosity of about 0.015 g/(cm)(sec) or above to be useful in the
methods, apparatus or automated system of the invention. For
example, solvents which exhibit less than the values described
above for one or more of the three physical properties can also be
used so long as the solvents maintain their ability to support
biopolymer synthesis and are capable of forming discrete
microdroplets without substantially initiating degradation of
components of the apparatus or automated system. Such solvents can
exhibit, for example, uncharacteristically high values for one or
more of three physical properties which can be compensated by a
corresponding decrease in the value of another one of the above
physical properties. Moreover, solvents that have values less than
those described above for either boiling point, surface tension or
viscosity can similarly be compensated by, for example,
substituting or modifying the components of the apparatus so as to
maintain the ability of the ink jet head, for example, to dispense
discrete microdroplets of solvent. Thus, the solvents of the
invention can exhibit values for one or more physical properties
less than those described above so long as they maintain their
function of supporting synthesis in microdroplets. Given the
teachings herein, those skilled in the art will know or can
determine which solvents can be used in the methods of the
invention.
PREPARATION OF MICRODROPLETS
[0079] The microdroplets of the present invention are preferably
obtained by forcing the solvent, at a rate of about 1 to about 10
m/sec, through an orifice or nozzle that has a diameter of about 10
to about 100 .mu.m. It is critical that the microdroplets so
obtained are dispensed from the orifice or nozzle in the form of
separate and discrete units.
[0080] One embodiment of the invention involves a system utilizing
a mechanism for localizing and separating microdroplets preferably
having a volume of about 100 pL or less, more preferably about 50
pL or less. The microdroplets are separated from each other, in the
form of microdots by, for example, hydrophobic domains. At such
small solvent volumes, surface tension is the strongest force that
acts on a microdroplet, and can be used, for example, to create
circular "surface tension wells" (FIG. 1a and FIG. 1b), preferably
arranged in arrays of microdots. Such surface tension wells can
constrain each microdot, and prevent adjacent microdots from
overlapping or merging with each other. According to the invention,
methods have been developed that produce an array of microdots that
are in the form of circular wells. The microdots define the
locations of the array elements, and act as miniature reaction
vessels for chemical synthesis. The microdots can vary in size and
will depend on the intended use of the synthesized array. For
example, the diameter of each microdot can be greater than 1000
.mu.m, but typically ranges from about 1 to about 1000 .mu.m,
preferably from about 10 to about 500 .mu.m, and more preferably
from about 40 to about 100 .mu.m. Similarly, the distance between
adjacent microdots will vary according to the intended use of the
array. The distance between each microdot is typically from about 1
to about 500 .mu.m, preferably from about 10 to about 100 .mu.m,
and more preferably from about 20 to about 30 .mu.m. Those skilled
in the art will know or can determine without undue experimentation
what is the appropriate separation of microdots within an array for
a particular use.
[0081] Physical separation of circular wells can be accomplished
according to known methods. For example, such methods can involve
the creation of hydrophilic wells by first applying a protectant,
or resist, over selected areas over the surface of a substrate. The
unprotected areas are then coated with a hydrophobic agent to yield
an unreactive surface. For example, a hydrophobic coating can be
created by chemical vapor deposition of
(tridecafluorotetrahydrooctyl)-triethoxysilane onto the exposed
oxide surrounding the protected circles. Finally, the protectant,
or resist, is removed exposing the well regions of the array for
further modification and nucleoside synthesis using the high
surface tension solvents described herein and procedures known in
the art such as those described by Maskos & Southern, Nucl.
Acids Res. 20:1679-1684 (1992). Alternatively, the entire surface
of a glass plate substrate can be coated with hydrophobic material,
such as 3-(1,1-dihydroperfluoroctyloxy)- propyltriethoxysilane,
which is ablated at desired loci to expose the underlying silicon
dioxide glass. The substrate is then coated with glycidyloxypropyl
trimethoxysilane, which reacts only with the glass, and which is
subsequently "treated" with hexaethylene glycol and sulfuric acid
to form an hydroxyl group-bearing linker upon which chemical
species can be synthesized (U.S. Pat. No. 5,474,796 to Brennan).
Arrays produced in such a manner can localize small volumes of
solvent within the circular wells by virtue of surface tension
effects (L'opez et al., Science 260:647-649 (1993)).
[0082] The protectant, or resist, can be applied in an appropriate
pattern by, for example, a printing process using a rubber stamp, a
silk-screening process, an inkjet printer, a laser printer with a
soluble toner, evaporation or by a photolithographic process, such
as that reported by Kleinfeld, D., J. Neurosci. 8:4098-4120 (1988).
The hydrophobic coating can also be applied directly in any
appropriate pattern by, for example, a printing process using a
rubber stamp, a silk-screening process, or laser printer with a
hydrophobic toner.
[0083] Additionally, the use of the present solvents allows for the
direct synthesis of chemical compound arrays onto a substrate such
as a silicon wafer or a glass slide without the need for creating
hydrophilic wells. Such direct synthesis is accomplished, for
example, by accurately depositing a microdroplet, of a solution
comprising a first chemical species, at each loci of the array. As
described above, inkjet print heads can be used for accurately
dispensing microdroplets in either single or multiple dispenser
format, i.e., from either a single nozzle or from multiple nozzles,
or with the dispensation of either a single microdroplet or of
multiple microdroplets.
[0084] The present invention also encompasses a method for
delivering a first chemical species to an appropriate locus of the
substrate. In one embodiment, microfabricated piezoelectric pumps,
or nozzles, similar to those used in inkjet printers, are used to
deliver a specified volume of solution to an appropriate locus of
the substrate (Kyser et al., J. Appl. Photographic Eng., 7:73-79
(1981)).
[0085] FIG. 2 shows an example of a piezoelectric pump, described
by way of example but not limitation as follows: The piezoelectric
pump is made by using etching techniques known to those skilled in
the art to fabricate a shallow cavity in silicon base 1. A thin,
glass membrane 3 is then anodically bonded to silicon base 1 to
seal the etched cavity, thus forming a small cavity 2 with narrow
inlet 5 and nozzle 7. When the end of inlet 5 of the piezoelectric
pump is dipped in the reagent solution, capillary action draws the
liquid into the cavity 2 until it comes to the end of the nozzle 7.
When an electrical pulse is applied to the piezoelectric element 4
glued to the glass membrane it bows inward, ejecting a microdroplet
6 out of the nozzle at the end of the piezoelectric pump. The
cavity refills itself through inlet 5 by capillary action. Simple
designs for piezoelectric pumps will operate at 1 thousand cycles
per second (kilo Hertz or kHz), while more advanced designs operate
at 6 kHz (See Takahashi et al., NEC Res. and Develop. 80:38-41
(1986)).
[0086] For chemical synthesis in two dimensional arrays,
piezoelectric pumps that will deliver on demand microdroplets
having a volume of about 100 pL of less, at rates of several
hundred Hz, are preferred. However, the microdroplet volume or
speed at which the piezoelectric pump can operate may vary
depending on the need. For example, if an array having a greater
number of microdots but with the same array surface area is to be
synthesized, then smaller microdroplets should be dispensed.
Additionally, if synthesis time is to be decreased, then the
operation speed of the microdroplet dispensing device can be
increased. Adjusting such parameters is within the purview of one
skilled in the art, and can be performed according to the need.
[0087] FIG. 3 shows substrate 8 being "scanned" (moved) across a
set of nozzles 9 using a computer-controlled X-Y translation stage
which translocates the nozzles relative to the substrate, or
preferably, translocates the substrate relative to the nozzles. The
computer synchronizes and times the firing of the nozzles 9 to
deliver a single microdroplet 10 of the appropriate first chemical
species 11 to each locus of the substrate.
[0088] FIG. 4 illustrates a cycle to synthesize an oligonucleotide.
It begins by delivering a solution comprising an appropriately
functionalized nucleoside either along with a catalyst such as
5-ethylthiotetrazole premixed with the nucleoside, or separately,
from a separate nozzle, to each well on the substrate. The entire
substrate can then be rinsed to remove excess monomer; exposed to
an oxidizing solution, typically an
iodine/tetrahydrofuran/pyridine/water mixture; and then rinsed with
acid to deprotect the 5' end of the oligonucleotide in preparation
for the next round of synthesis. The rinses can be common to all
the microdots of the substrate and can be performed, for example,
by bulk immersion of the substrate. One such iteration adds a first
chemical species to each growing oligomer; thus, an array of
oligomers having a length of ten units each requires 10 such
iterations.
[0089] The number of iterations, and therefore, the length of the
oligomers obtained, will be determined by the need and desired use
for the array. As such, the oligomer lengths which can be achieved
using the methods of the invention are limited only by existing
coupling chemistries. Routinely, oligomers having about 10 to about
100, and preferably having about 20 to about 60 units each can be
synthesized. As new coupling chemistries emerge, so will the yield
and length of oligomeric products. Therefore, it is envisioned that
the methods of the invention are useful for the synthesis of
oligomer arrays of greater than 100 units each.
[0090] Inkjet printers generally contain print heads having 50 to
100 independently controlled nozzles. With each nozzle operating at
several hundred Hz, an apparatus with five such heads can deliver a
microdroplet of a solvent comprising a first chemical species to
100,000 different loci in a matter of seconds. A complete synthesis
cycle can take, for example, 5 minutes, or just over 2 hours for an
array of 100,000 oligomers having 25 units each. Inkjet print heads
having a greater or fewer number of nozzles, and which operate at
different speeds, can be used as well. Additionally, multiple heads
can be simultaneously used to synthesize the arrays. Such
modifications are known to those skilled in the art and will vary
depending on the size, format and intended use of the assay.
CHEMICAL SYNTHESIS USING MICRODROPLETS
[0091] The microdroplets of the present invention further comprise
a first chemical species which is soluble in a solvent of the
invention described in Section 5.2. Typically, upon formation, the
microdroplet is a solution of the first chemical species having a
concentration of about 1 nM to about 5M, preferably from about 0.01
mM to about 1M. The microdroplet impinges a second chemical
species, and the first chemical species of the microdroplet reacts
with the second chemical species to form a third chemical species,
the third chemical species being different from the first and
second chemical species. In this manner, and particularly when the
second chemical species is linked to a substrate, arrays of
different chemical compounds, arranged in microdots which are
separate and discrete units, can be synthesized.
[0092] The first chemical species is any chemical compound that can
react with a second chemical species so as to form a third chemical
species. The first chemical species and the second chemical species
can be the same or different, but the third chemical species must
be different from the first chemical species and the second
chemical species. The process of reacting a first chemical species
with a second chemical species to form a third chemical species may
be repeated at the site of the third chemical species, such that in
a subsequent iteration of the process, the third chemical species
becomes the "second chemical species" with respect to an impinging
microdroplet comprising a first chemical species, and the reaction
product of that "second chemical species" and the first chemical
species is a new third chemical species that is different from the
original third chemical species. Accordingly, as used herein,
"second chemical species" is that which reacts with a first
chemical species, and "third chemical species" is the reaction
product of the first chemical species and second chemical species.
An unlimited number of iterations of this process can be performed
until the desired chemical compound is synthesized. In a specific
embodiment, the third chemical species is an oligomer (e.g., a
homo-oligomer or hetero-oligomer), preferably a biopolymer,
containing as monomer units the first and second chemical
species.
[0093] In one embodiment, the first chemical species reacts with
the second chemical species in the presence of a catalyst.
Accordingly, the solution can optionally comprise a catalyst, such
as an enzyme or other chemical catalyst, that accelerates the rate
of reaction between the first chemical species and second chemical
species. Alternatively, if it is advantageous that the first
chemical species react with the second chemical species in the
presence of a catalyst, a solution comprising a catalyst can be
delivered to the locus where the first chemical species impinges
the second chemical species either prior or subsequent to the
impingement of the second chemical species by the first chemical
species.
[0094] For ease of handling, the second chemical species can be
associated with a substrate. By "associated with" is meant (a)
adheres, but is not chemically attached, to, such as for example
where the second chemical species is in the form of a microdot on a
substrate of paper or untreated glass, or in solution sitting in a
microwell or microcavity of the substrate; or (b) is chemically
attached to, such as for example where the second chemical species
is covalently bonded directly to a functional group of the
substrate, or bonded to a linker that is attached to the
substrate.
[0095] As used herein, the term "substrate" is intended to mean a
generally flat surface, porous or not, which has, or can be
chemically modified to have, reactive groups suitable for attaching
further organic molecules. Examples of such substrates include, but
are not limited to, glass, silica, silicon, polypropylene,
TEFLON.RTM., polyethylimine, nylon, fiberglass, paper, and
polystyrene. Bead structures may also be attached to the surface of
the substrate, wherein the beads are composed of one or more of the
preceding substrate materials. As used herein, substrates which
contain or are modified to contain chemically reactive species can
therefore also be referred to as a "chemical species."
[0096] Where the third chemical species is to be assayed, for
example, for biological activity, it is preferable that the third
chemical species be readily removable from the substrate: e.g., in
the case where the third chemical species adheres, but is not
chemically attached, to, the substrate, by washing with a suitable
solvent; in the case where the third chemical species is in
solution sitting in a microwell or microcavity of the substrate, by
removing the solution via a micropipetting or microsyringing
device; and in the case where the third chemical species is
chemically attached to the substrate (either directly or via a
linker), by releasing, preferably hydrolyzing or enzymatically
cleaving, the third chemical species from the substrate or linker
attached to the substrate. It will be understood that in the latter
instance, the third chemical species so released will be slightly
chemically modified relative to the attached third chemical
species; for example, where the third chemical species is attached
to an hydroxyl or amino group of the substrate via an ester or
amide bond, the third chemical species so hydrolyzed will have a
terminal carboxyl or carboxylate group. Accordingly, the term
"third chemical species" is also meant to encompass the chemical
species that is ultimately released from the substrate.
[0097] In one embodiment, the first chemical species is, for
example, a nucleoside, activated nucleoside, or nucleotide; the
second chemical species is, for example, a substrate having
reactive functional groups, a linker attached to a substrate, or a
nucleoside, nucleotide, or oligonucleotide attached to either the
linker or directly to the substrate; and the third chemical species
is a nucleoside activated nucleoside, or nucleotide (in the case
where the second chemical species is a substrate or linker attached
to a substrate) or an oligonucleotide of at least two nucleoside
units (in the case where the second chemical species is a
nucleoside or oligonucleotide), chemically attached to either the
linker or directly to the substrate.
[0098] Preferably, the first chemical species is a nucleoside
having an activated phosphorous-containing, preferably a
phosphoramidite, group at the 3' position, and a protected hydroxyl
group at the 5' position, and the second chemical species is (a) a
substrate or linker attached to a substrate having an thiol or
hydroxyl group that is capable of forming a stable, covalent bond
with the phosphoramidite group at the 3' position of the first
chemical species, or (b) a nucleoside or oligonucleotide attached
to either the linker or directly to the substrate, and having an
thiol or hydroxyl group at its 5' position that is capable of
forming a stable, covalent bond with the phosphoramidite group at
the 3' position of the first chemical species.
[0099] Thus, where the first chemical species is a nucleoside, the
present invention encompasses a solution, preferably in
microdroplet form, comprising a solvent and a nucleoside, wherein
the solvent has a boiling point of 150.degree. C. or above, a
surface tension of 30 dynes/cm or above, and a viscosity of 0.015
g/(cm)(sec) or above. Preferably, the solvent is represented by the
formula (I), described in Section 5.2, above.
[0100] As used herein, the term "nucleoside" encompasses both
deoxyribonucleosides and ribonucleosides, and the term
"oligonucleotide" refers to an oligonucleotide that comprises
deoxyribonucleotide or ribonucleotide units, such that the term
"oligonucleotide" encompasses both oligodeoxyribonucleotides and
oligoribonucleotides.
[0101] Where the first chemical species and second chemical species
bear additional reactive groups, such as for example primary amino
groups of adenine, cytosine and guanine bases, those reactive
groups can have additional protecting groups, so as to preclude
unwanted side reactions if not protected. The primary amino groups
of adenine, cytosine and guanine bases are protected with amino
protecting groups well known to those skilled in the art,
preferably, with t-butylphenoxyacetyl (tBPA) groups.
[0102] Typically, by way of example, a solution comprising a
nucleoside as the first chemical species and having (a) a
protecting group, preferably a monomethoxytrityl or dimethoxytrityl
protecting group, on the 5' hydroxyl group, (b) an activated
phosphorous-containing group at the 3' position, and (c) another
protecting group, preferably a tBPA group, at any primary amino
group of the base portion of the nucleoside, in a solvent of the
invention is dispensed as a microdroplet onto a second chemical
species, e.g., a substrate or a substrate with a linker having, for
example, hydroxyl functional groups.
[0103] Suitable nucleosides useful for the synthesis of
oligonucleotides according to the present methods are those
nucleosides that contain activated phosphorous-containing groups
such as phosphodiester, phosphotriester, phosphate triester,
H-phosphonate and phosphoramidite groups. It will be understood
that where the first chemical species is a nucleoside, and the
second chemical species is a nucleoside or an oligonucleotide, the
first and second chemical species have the same activated
phosphorous-containing group. Such activated nucleosides and their
relevant chemistries are described in, for example, Nucleic Acids
in Chemistry and Biology (Blackburn and Gait eds., 2d ed. 1996) and
T. Atkinson et al., Solid-Phase Synthesis of
Oligodeoxyribonucleotides by the Phosphite-Triester Method, in
Oligonucleotide Synthesis 35-39 (M. J. Gait ed., 1984). Preferably,
the activated phosphorous-containing group is a phosphoramidite,
more preferably a phosphoramidite having a cyanoethyl group, and
most preferably, a phosphoramidite having the formula
(iPr.sub.2N)P(OCH.sub.2CH.sub.2CN)OR, where R is the 3' position of
a nucleoside. By way of example but not limitation, a detailed
example of oligonucleotide synthesis using a phosphoramidite
nucleoside derivative is described below.
[0104] The reaction between the 3' phosphoramidite group of the
nucleoside, and the hydroxyl groups of the substrate-bound linker,
is facilitated by a catalyst, such as 5-methylthiotetrazole,
tetrazole, or preferably 5-ethylthiotetrazole. The solution of
nucleoside can additionally comprise the catalyst or preferably,
following dispensation of the nucleoside solution, an additional
microdroplet of catalyst solution can be dispensed upon the locus
at which the nucleoside solution impinged the substrate-bound
linker. The reaction between the hydroxyl groups of the
substrate-bound linker, and the 3' phosphoramidite group of the
nucleoside, preferably performed in the presence of the catalyst,
forms a protected nucleoside anchored to the substrate via a 3'
phosphite group. This protected nucleoside is now the third
chemical species. Preferably, the entire substrate is washed with a
solvent, e.g., acetonitrile or dichloromethane, before proceeding
to the next step. It will be appreciated that a phosphoramidite
group will form a phosphite group, preferably in the presence of a
catalyst, with a hydroxyl group in general. Such an hydroxyl group
may be either a primary, secondary or tertiary alcohol, or may be
of a silanol. The phosphite group is oxidized to a phosphate group
in the presence of an oxidizing agent. Additionally, a
phosphoramidite group will form a thiophosphite group, preferably
in the presence of a catalyst, with a thiol group in general. Such
a thiol group may be either a primary, secondary or tertiary thiol.
The thiophosphite group can be oxidized to a thiophosphate group in
the presence of an oxidizing agent.
[0105] The resulting 3' phosphite group is then oxidized to a 3'
phosphate group. Preferably, the oxidizing agent used to oxidize
the phosphite group to the phosphate group is iodine, more
preferably, a solution of iodine, water, an organic base such as
pyridine, and an organic solvent such as tetrahydrofuran.
Preferably, the entire substrate, to which the nucleoside having
the 3' phosphite group is attached, is washed with the oxidizing
agent, oxidizing the 3' phosphite group to the 3' phosphate group.
In one embodiment of the invention, the substrate, to which the
nucleoside having the 3' phosphite group is attached, is submerged
in a bath containing the oxidizing agent. Alternatively, the
oxidizing agent can be dispensed as a microdroplet onto the locus
at which the nucleoside, having the 3' phosphite group, is
synthesized. In such an instance, the oxidizing agent is preferably
dispensed as a solution in a solvent described in Section 5.2.
Following treatment with the oxidizing agent, and before proceeding
to the next step, the entire substrate is preferably washed with a
solvent, e.g., acetonitrile or dichloromethane.
[0106] Following oxidation, the entire substrate, to which the
nucleoside having the 3' phosphate group is attached, is treated
with a reagent that "caps" the unreacted hydroxyl groups of the
substrate-bound linker so as to prevent them from competing for the
phosphoramidite group of a subsequently dispensed nucleoside with
the 5' position of the newly added nucleoside, above. Preferably,
the capping reagent is an acylating agent, more preferably, an acyl
halide and most preferably, perfluorooctanoyl chloride. Preferably,
the entire substrate is washed with a solvent, e.g., acetonitrile
or dichloromethane, before proceeding to the next step.
[0107] In the next step, the nucleoside having the 3' phosphate
group that is covalently bonded to the linker of the substrate is
treated with a first deprotecting agent which removes the
protecting group from the bound nucleoside's 5' position, exposing
a reactive hydroxyl group at the 5' position. Preferably, the first
deprotecting agent is an acid, and more preferably dichloroacetic
acid. In a preferred embodiment, the entire substrate to which the
nucleoside having the 3' phosphate group is bonded is rinsed with a
solution of the first deprotecting agent. Alternatively, the first
deprotecting agent can be dispensed as a microdroplet; in such a
case, the microdroplet preferably comprises a solvent described in
Section 5.2. Before proceeding to the next step, the entire
substrate is preferably washed with a solvent, e.g., acetonitrile
or dichloromethane.
[0108] In the following step, a second nucleoside having an
activated phosphorous-containing, preferably a phosphoramidite,
group at the 3' position, and a protected hydroxyl group at the 5'
position, is dispensed as a microdroplet solution using a solvent
described in Section 5.2 so as to impinge the microdot.
[0109] The solution of nucleoside can additionally comprise a
catalyst, or alternatively, in a subsequent step, a microdroplet of
a solution of catalyst, such as 5-methylthiotetrazole, tetrazole,
or preferably 5-ethylthiotetrazole, preferably in a solvent
described in Section 5.2, is dispensed upon the locus at which the
second nucleoside solution impinged the microdot. The catalyst
facilitates a reaction between the 5' hydroxyl group of the first
nucleoside and the 3' phosphoramidite group of the second
nucleoside, resulting in the coupling of the second nucleoside to
the first nucleoside via a phosphite group, as described above.
[0110] At this point, successive iterations of (a) oxidizing the
resulting phosphite to a phosphate group; (b) removing the 5'
protecting group; (c) dispensing an additional protected nucleoside
having a phosphoramidite group at its 5' position, optionally in
the presence of catalyst or, preferably; (d) dispensing the
catalyst at the locus where the additional nucleoside was
dispensed, preferably with solvent washing subsequent to performing
each of iterative steps (a)-(d), affords a linker-bound
oligonucleotide that has a 2-cyanoethylphosphate group, as well as
a protecting group, preferably a tBPA protecting group, on any
primary amino group of the nucleoside bases.
[0111] Treatment with a second deprotecting agent, preferably
ethanolamine, removes the protecting groups from the nucleoside
bases, and converts the oligonucleotide 2-cyanoethylphosphate
groups to phosphate groups. Preferably, the entire substrate to
which the oligonucleotide is bonded is rinsed with a solution of
the second deprotecting agent. Alternatively, the second
deprotecting agent can be dispensed as a microdroplet; in such a
case, the microdroplet preferably comprises a solvent described in
Section 5.2.
[0112] The chemistry relating to the above-described example of
oligonucleotide synthesis is summarized below in Scheme 1: 3
[0113] It is to be pointed out that this process may be repeated at
different loci of the substrate, using different first chemical
species and second chemical species, so as to obtain, if desired, a
different oligonucleotide at each loci.
[0114] The oligonucleotides thus synthesized can be used in their
substrate-anchored form, e.g., in hybridization assays conducted on
the substrate. Alternatively, in another embodiment of the
invention, the substrate-anchored oligonucleotides obtained above
can be cleaved from the substrate. In a specific embodiment, the
nucleoside unit of the oligonucleotide that is directly attached to
the substrate, or, attached to a linker that is attached to the
substrate, is attached to the substrate, or to the linker, via an
ester bond. Such an ester bond is susceptible to hydrolysis via
exposure to a hydrolyzing agent. Such an ester bond is preferably
formed on the first nucleoside prior to application to the
substrate. In this embodiment, prior to synthesis of the
oligonucleotide to be cleaved, an amino group, preferably in the
form of a long chain alkylamine, is attached to the substrate (see
T. Atkinson et al., Solid Phase Synthesis of
Oligodeoxyribonucleotides by the Phosphitetriester Method, in
Oligonucleotide Synthesis (M. J. Gait ed., 1984). The first
nucleoside having the ester bond is attached to the amino group of
the substrate via an activated O-succinate group (Scheme 2, below,
and T. Atkinson et al., Solid-Phase Synthesis of
Oligodeoxyribonucleotides by the Phosphitetriester Method, in
Oligonucleotide Synthesis (M. J. Gait ed., 1984), which reacts with
the amino group of the substrate to form an amide bond therewith.
As used herein, "activated" O-succinate groups are those that have,
at the succinate carbonyl group not attached to the nucleoside, a
leaving group that is capable of being displaced by an amino group,
preferably an amino group of a substrate. Preferably, the activated
O-succinate group is one that has, at the succinate carbonyl group
not attached to the nucleoside, a p-nitrophenoxy group. Methods for
preparing activated O-succinate groups are well known to those
skilled in the art. Such an activated nucleoside can be applied to
the substrate as a microdroplet solution. 4
[0115] It should be noted that in the instance where a polymer
containing both nucleoside and non-nucleoside monomer units is
desired to be synthesized, a second or subsequent chemical species
to be bonded to the first nucleoside can be any
phosphoramidite-containing compound, such as for example,
phosphoramidite-modified amines, thiols, disulfides, ethylene
glycols and cholesterol derivatives. Such
phosphoramidite-containing compounds are commercially available
from Glen Research, Sterling, Va.
[0116] Hydrolyzing agents that can thus be used to cleave the
oligonucleotide from the substrate are well known to those skilled
in the art and include hydroxide ion (e.g., as an aqueous solution
of sodium hydroxide), CH.sub.3NH.sub.2 or preferably, concentrated
aqueous NH.sub.4OH. In a preferred embodiment, the entire substrate
to which the oligonucleotide, having phosphate groups, is bonded is
rinsed with a solution of the hydrolyzing agent. Alternatively, the
hydrolyzing agent can be dispensed as a microdroplet; in such a
case, the microdroplet preferably comprises a solvent described in
Section 5.2.
[0117] Where the nucleoside, as the first chemical species, is
attached to the substrate, or linker of the substrate, via an ester
bond, it will be understood that prior to reaction with an
additional nucleoside, the first added nucleoside is deprotected
with a deprotecting agent which removes a protecting group from its
5' position. The subsequently dispensed nucleoside, having a
phosphoramidite group at its 3' position, reacts with the
nucleoside attached via the ester bond to the substrate or linker
of the substrate, and having a deprotected hydroxyl group at its 5'
position, to form a phosphite group. The resulting phosphite group
is than treated with an oxidizing agent, described above, to form a
phosphate group. Successive iterations of deprotection, treatment
with a phophoramidite functionalized nucleoside, and oxidation,
elongate the resulting oligonucleotide chain.
[0118] In a different specific embodiment, a linker, attaching the
first chemical species' nucleoside unit to the substrate, contains
a protease recognition site that, after synthesis of the
oligonucleotide, is cleaved by use of the protease to release the
substrate-anchored oligonucleotide. The entire substrate is
preferably rinsed with a reaction mixture containing the protease;
alternatively, the protease can be delivered as a microdroplet
solution to the desired location on the substrate where the
oligonucleotide is tethered.
[0119] The resulting cleaved oligonucleotide is preferably soluble
in the solution of hydrolyzing agent or protease, as the case may
be. Where the solution of hydrolyzing agent or protease, in which
the substrate can be immersed, is contained in a vessel, the vessel
will contain the cleaved oligonucleotide upon immersion of the
oligonucleotide-anchored substrate into the hydrolyzing agent or
protease solution. Methods for isolating and purifying the cleaved
oligonucleotide are well known to those skilled in the art, and
include, but are not limited to, gel electrophoresis and
high-performance liquid chromatography.
[0120] The isolated and/or purified oligonucleotide obtained by the
above methods can be used as known in the art, e.g., in
hybridization assays, for expression analysis or genotyping; as
sequencing or polymerase chain reaction (PCR) primers; or as
templates for synthesis of oligonucleotide probes, etc.
[0121] It is to be understood that while the preferred method of
synthesis of an oligonucleotide is in the 3'-5' direction, the
present invention also provides methods for synthesizing
oligonucleotides in the 5'-3' direction. Oligonucleotides produced
having this direction are useful for enzymatic reactions, such as
polymerization via DNA polymerase, while remaining attached to a
substrate.
[0122] In the instance of synthesizing an oligonucleotide in the
5'-3' direction, a nucleoside having an hydroxyl protecting group
at its 3' position, and a phosphoramidite at its 5' position, is
attached to the substrate. Preferably, and alternatively, a
nucleoside having an hydroxyl protecting group at its 3' position,
and an activated O-succinate group at its 5' position is attached
to the substrate. The nucleoside having an hydroxyl protecting
group at its 3' position, and a phosphoramidite or an activated
O-succinate group at its 5' position, is preferably applied to the
substrate in a microdroplet of solution, preferably from an inkjet
nozzle. Where the nucleoside has a phosphoramidite at its 5'
position, the substrate used has an hydroxyl group, which reacts
with the nucleoside's 5' phosphoramidite group to form a phosphite
group, which can then be converted to a phosphate group. Where the
nucleoside has an activated O-succinate group at its 5' position,
the substrate used has an amino group, more preferably an amino
group in the form of a long chain alkylamine, which reacts with the
nucleoside's 5' activated O-succinate group to form an amide bond.
Where the nucleoside has a phosphoramidite group at its 5'
position, the esterification reaction between the phosphoramidite
group and the hydroxyl group of the substrate is facilitated by a
catalyst, as described above.
[0123] Once the nucleoside is anchored to the substrate, the 3'
protecting group is removed as described above for the analogous 5'
protecting group, preferably by rinsing the substrate with
deprotecting agent, so as to expose a 3' hydroxyl group. Then, a
second nucleoside having a phosphoramidite, preferably having a
cyanoethyl group, at its 5' position, and having a protecting group
at its 3' position, is dispensed, as a microdroplet of solution, at
the locus of the substrate where the first nucleoside was added.
Following dispensation of the second nucleoside, a catalyst, such
as one described above, is dispensed, preferably as a microdroplet
of solution, at the locus of the substrate where the second
nucleoside was added, to facilitate coupling between the first and
second nucleosides. The reaction between the 3' hydroxyl group of
the first nucleoside and the 5' phosphoramidite group of the second
nucleoside forms a phosphite group, which is oxidized as described
above to form a phosphate group. Where the substrate has a hydroxyl
group that reacts with a nucleoside's 5' phosphoramidite group, it
may be desirable to "cap" remaining substrate hydroxyl groups, as
described above, before proceeding to the subsequent steps.
[0124] Successive iterations of deprotection, dispensation of an
additional nucleoside, dispensation of catalyst and oxidation
steps, elongates the oligonucleotide chain. Then, as described
above, the cyanoethyl groups of the resulting oligonucleotide are
removed. Finally, the resulting oligonucleotide is hydrolyzed from
the substrate, using a hydrolyzing agent described above.
[0125] In addition, the present invention provides syntheses of
oligonucleotides having 5'-5' or 3'-3' linkages. Oligonucleotides
having these linkages are useful for antisense and structural
studies. Such oligonucleotides are obtained according to the
general methods above, and using a combination of nucleosides
having an hydroxyl protecting group at the 5' position and a
phosphoramidite group at the 3' position, and vice versa. For
example, a nucleoside having a deprotected hydroxyl group at its 5'
position that is anchored to a substrate via the nucleoside's 3'
group can react, preferably in the presence of a catalyst, with a
second nucleoside having a phosphoramidite group at its 5' position
and a protecting group at its 3' position, to form a 5'-5' linkage.
The resulting phosphite group is oxidized to a phosphate group, and
the protecting group from the second nucleoside's 3' position is
removed. Similarly, a third nucleoside having a phosphoramidite
group at its 3' position and a protecting group at its 5' position
can react, preferably in the presence of a catalyst, with the
exposed 3' hydroxyl group of the second nucleoside to form a 3'-3'
linkage. Once the resulting phosphite group is oxidized to a
phosphate group, the synthesis can be continued using a nucleoside
having either a phosphoramidite group at its 5' position and a
protecting group at its 3' position, or a phosphoramidite group at
its 3' position and a protecting group at its 5' position,
depending upon the type of linkage desired. Where it is desired
that the resulting oligonucleotide be cleaved from its substrate,
the substrate preferably has an amino group, more preferably an
amino group in the form of a long chain alkylamine, that reacts
with a first nucleoside that has an activated O-succinate group at
its 3' position and a protecting group at its 5' position, or an
activated O-succinate group at its 5' position and a protecting
group at its 3' position.
[0126] In yet another embodiment, the invention provides a method
for obtaining oligonucleotides, having 3'-5', 5'-3', 3'-3' or 5'-5'
linkages, using the H-phosphonate method for oligonucleotide
synthesis (see, for example, chapter 6 of J. F. Ramalho Ortigo et
al., Introduction to Solid-phase Oligonucleotide Chemistry
(http://www.interactiva.de/oligoman- /intro_inh.html)). In this
instance, where the oligonucleotide to be synthesized is ultimately
sought to be cleaved from the substrate, a substrate having an
amino group is reacted with a nucleoside having a protecting group
at its 5' position and an activated O-succinate group at its 3'
position, or having a protecting group at its 3' position and an
activated O-succinate group at its 5' position; where the
oligonucleotide is not to be subsequently cleaved from the support,
the support can have an hydroxyl group, which is reacted,
preferably in the presence of a catalyst, with a nucleoside having
a protecting group at its 5' position and a phosphoramidite group
at its 3' position, or having a protecting group at its 3' position
and a phosphoramidite group at its 5' position. It is to be
understood that the nucleoside reagents are delivered as
microdroplets of solutions, preferably from inkjet nozzles.
[0127] Following removal of the protecting group, which exposes a
reactive hydroxyl group, a second nucleoside, having an
H-phosphonate salt group at its 5' position and a protecting group
at its 3' position, or having an H-phosphonate salt group at its 3'
position and a protecting group at its 5' position, is dispensed as
a microdroplet solution at the locus of the support at which the
first nucleoside was added. Useful H-phosphonate salts are those
that are soluble in the solvents discussed in Section 5.2 above;
preferably, the H-phosphonate salts are triethylammonium salts, or
salts of 1,8-diazabicyclo[5.4.0.]undec-7-en (DBU). The reaction
product of the H-phosphonate salts and the exposed hydroxyl group
is an H-phosphonate diester.
[0128] Advantageously, the H-phosphonate salts react with the
exposed hydroxyl group of the substrate-bound nucleoside in the
presence of an activator which, without being bound to any
particular theory, is believed to increase the electrophilicity of
the H-phosphonate group. Suitable activators include but are not
limited to acid chlorides, preferably pivaloyl chloride and
1-adamantane carbonyl chloride; and anhydrides, preferably
dipentafluorophenyl carbonate. The activators can be dispensed as a
microdroplet with the H-phosphonate salts as part of the same
solution, or can be dispensed as separate microdroplets from
separate solutions. Successive dispensations of H-phosphonate
salt/activator solutions as microdroplets, or successive iterations
of separate H-phosphonate salt and activator dispensation steps,
elongates the resulting oligonucleotide chain.
[0129] Once the oligonucleotide has reached its desired length, the
H-phosphonate diester linkages are oxidized using conventional
reagents, preferably an aqueous iodine solution, to afford
phosphate groups. The oxidizing agent can be dispensed as a
microdroplet comprising a solvent described in Section 5.2;
alternatively, the entire substrate to which the oligonucleotide is
attached can be washed with the oxidizing reagent. The
oligonucleotide can then be cleaved from the substrate according to
methods described above.
[0130] In addition to the chemistries described above, alternative
reactions can be used in the methods of the invention where
oligomers comprising modified nucleosides or nucleoside derivatives
are synthesized. Such modified nucleosides include, for example,
combinations of modified phosphodiester linkages such as
phosphorothioate, phosphorodithioate and methylphosphonate, as well
as nucleosides having such modified bases such as inosine,
5'-nitroindole and 3' -nitropyrrole.
[0131] Synthesis of oligoribonucleotides, e.g., RNA, can similarly
be accomplished using the present methods. Effective chemical
methods for oligoribonucleotide synthesis have added complications
resulting from the presence of the ribose 2'-hydroxyl group.
However, ribonucleoside coupling chemistries and protecting groups
are available and well known to those skilled in the art.
Therefore, such chemistries are applicable to the methods described
herein.
[0132] As with oligodeoxyribonucleotides described above, a range
of modifications can similarly be introduced into the base, the
sugar, or the phosphate portions of oligoribonucleotides, e.g., by
preparation of appropriately protected phosphoramidite or
H-phosphonate ribonucleoside monomers, and/or coupling such
modified forms into oligoribonucleotides by solid-phase synthesis.
Modified ribonucleoside analogues include, for example,
2'-O-methyl, 2'-O-allyl, 2'-fluoro, 2'-amino phosphorothioate,
2'-O-Me methylphosphonate, .alpha.-ribose and 2'-5'-linked
ribonucleoside analogs.
[0133] In another preferred embodiment, the first chemical species
is an amino acid; the second chemical species is a substrate having
reactive functional groups, a linker attached to a substrate, or an
amino acid or peptide attached to either the linker or directly to
the substrate; and the third chemical species is an amino acid or a
peptide chemically attached to either the linker or directly to the
substrate. In this embodiment, the first chemical species is an
amino acid having a protecting group on the carboxy group of its
carboxy terminus, and the second chemical species is (a) a
substrate, or a linker attached to a substrate, having an
electrophilic group that is capable of forming a stable covalent
bond with the amino group of the amino terminus of the amino acid,
or (b) an amino acid or peptide attached to either the linker or
directly to the substrate, and having a carboxy terminus that is
capable of forming an amide bond with the amino group of the amino
terminus of the amino acid. Alternatively and preferably, the first
chemical species is an amino acid having a protecting group on the
amino group of its amino terminus, and the second chemical species
is (a) a substrate or a linker attached to a substrate having a
nucleophilic group that is capable of forming a stable covalent
bond with the carboxy terminus of the amino acid, or (b) an amino
acid or peptide attached to either the linker or directly to the
substrate, and having an amino terminus that is capable of forming
an amide bond with the carboxy terminus of the amino acid. It will
be understood that if the first chemical species and second
chemical species bear additional reactive groups, those reactive
groups can have additional protecting groups, so as to preclude
unwanted side reactions with those groups if not protected.
[0134] Advantageously, where peptides are sought to be obtained,
the reaction between the first chemical species and the second
chemical species takes place in the presence of a catalyst;
preferably, a stoichiometric amount of a catalyst such as
dicyclohexylcarbodiimide or the like. In such a case the
microdroplet solution can comprise the catalyst as well as the
first chemical species.
[0135] Typically, a solution comprising an amino acid having a
protecting group on the amino group of its amino terminus as the
first chemical species and a stoichiometric amount of
dicyclohexylcarbodiimide catalyst, is dispensed as a microdroplet
onto a second chemical species, e.g., a substrate with a linker
having, for example, hydroxyl functional groups, thereby forming a
microdot containing an amino acid covalently bonded to the linker
of the substrate via an ester bond as the third chemical
species.
[0136] It is to be pointed out that suitable protecting groups for
the amino group of the amino terminus of an amino acid include
tert-butoxycarbonyl (tBOC) and 9-fluorenylmethoxycarbonyl (FMOC)
protecting groups, and other protecting groups disclosed in
Theodora W. Greene, Protecting Groups in Organic Synthesis 218-49
(1981), incorporated herein by reference.
[0137] The resulting N-protected amino acid that is covalently
bonded to the linker of the substrate is then treated with a
deprotecting agent that can remove the protecting group from the
amino group of the amino acid's amino terminus: in the case where a
tBOC protecting group is used, the deprotecting agent is an acid
such as HCl or trifluoroacetic acid; in the case where an FMOC
protecting group is used, the deprotecting agent is an organic base
such as piperidine, morpholine or ethanolamine. The protecting
group can be removed by immersing or otherwise washing the
substrate in a bath or stream of a solution of the deprotecting
agent. Alternatively, the deprotecting agent can be added, in the
form of a microdroplet, onto the N-protected amino acid that is
covalently bonded to the linker of the substrate. In such a case,
the microdroplet preferably comprises a solvent described in
Section 5.2.
[0138] The resulting deprotected amino acid that is covalently
bonded to the linker of the substrate, becomes the second chemical
species relative to an impinging microdroplet of a solution of
either the same or a different amino acid having a protecting group
on the amino group of its amino terminus, and so on. The entire
process is repeated until a peptide having a desired sequence or
length is obtained.
[0139] It is to be pointed out that this process may be repeated at
different loci of the substrate, using different first chemical
species and second chemical species, so as to obtain, if desired, a
different peptide at each loci.
[0140] The resulting peptide which is covalently attached to the
linker of the substrate, and which has a protecting group on the
amino group of its amino terminus, is treated, either via
submersion of the substrate or via microdroplet impingement as
described above, with a deprotecting agent that removes that
protecting group and preferably all of the remaining protecting
groups on the peptide, if any. If protecting groups remain on the
peptide subsequent to treatment with the deprotecting agent,
subsequent treatments with deprotecting agents can be effected
until all of the protecting groups have been removed.
[0141] If desired, the resulting deprotected peptide synthesized by
the above method can then be cleaved from the linker using
conditions that will hydrolyze an ester bond in the presence of an
amide bond, including treatment with mild hydroxide base, as well
as other suitable conditions known to those skilled in the art.
[0142] The methods of the invention can be applied to other
chemistries that rely on iterations of coupling and deprotection.
For example, using the present methods, it is possible to construct
arrays of other heteromeric polymers with sequence dependent
properties.
[0143] It will be realized that a particular advantage of the
method of the invention is that by keeping a record of the first
chemical species dispensed, and accordingly third chemical species
formed, at each of the microdot loci, libraries of chemical
compounds having known sequences can be easily obtained. Such
chemical compounds can have a variety of uses including, but not
limited to, screening for biological activity whereby the
respective chemical compound at each locus is exposed to a labeled
or unlabeled nucleic acid or receptor, such as an antibody, a cell
receptor, or any other variety of receptor.
[0144] The following examples are presented by way of illustration
and not by limitation on the scope of the invention.
AUTOMATED SYNTHESIS SYSTEM
[0145] The methods of the invention for chemical synthesis using
microdroplets are preferably automated. Preferably, the methods are
automated as described below, using the exemplary apparatus and
software as described herein.
SYSTEM IMPLEMENTATION
[0146] Shown in FIG. 5 is a preferred embodiment of an automated
system for large-scale synthesis of biopolymers in accordance with
the invention. As used herein, the term biopolymer is intended to
mean any of numerous biologically occurring compounds which are
synthesized from two or more individual monomer building blocks.
Nucleic acids, polypeptides and carbohydrates are specific examples
of biopolymers. The individual monomers for these biopolymers
consist of nucleosides, amino acids and sugars, respectively. The
term is intended to include natural and non-naturally occurring
monomers as well as derivatives, analogues, and mimetics
thereof.
[0147] The automated system is designated by reference numeral 20.
Generally, system 20 comprises scanning transport 22, treating
transport 23, a print head assembly 24, an alignment unit 26, a
transfer station 28, a flow cell 30, and a substrate storage rack
32. The components are mounted, for example, on a base 34, and
enclosed by a cover (not shown) so that processing can be performed
in a dry nitrogen environment.
[0148] The components are used to manipulate a planar substrate and
to synthesize biopolymers on the substrate under the automated
control of a computer. The substrate used for the synthesis of
two-dimensional biopolymer arrays is generally a wafer having a
flat planar surface which has, or can be modified to have, reactive
groups suitable for attaching further organic molecules. The
substrate can additionally be porous so long as it supports the
synthesis of biopolymer arrays. Specific examples of substrates
useful in the automated system of the invention include glass,
silica, silicon, polypropylene, TEFLON.RTM., polyethylimine, nylon,
fiberglass, paper and polystyrene. The surface can additionally
consist of bead structures attached to a solid surface, wherein the
beads are composed of one or more of the preceding materials. The
dimensions of the substrate can vary and are determined to be
complementary to the supporting structures of the automated system.
The dimensions can be altered depending on the desired size and
application of the array and the design of the supporting
structures which hold the substrate.
[0149] The substrate is cycled once over the print head assembly to
make a single deposit of a chosen biopolymer monomer at each
desired site. In this single cycle, different sites can receive
different monomers. For the synthesis of nucleic acid biopolymers,
for example, any one of the four monomers is available for any
particular site during any single print head cycle. A catalyst is
applied by the print head to each substrate site after the monomers
are deposited.
[0150] After a print head cycle, treating transport 23 is used to
move the substrate from the print head assembly to flow cell 30,
which "treats" the substrate by exposing it to selective fluids in
order to rinse off unconnected monomers, oxidize, and deprotect the
substrate. Once rinsed, the substrate is moved again to print head
assembly 24 for a further cycle of monomer deposits, and then
rinsed again in the flow cell. These steps are repeated numerous
times to build desired biopolymer sequences. Different biopolymer
sequences can be assembled at each site by using different
sequences of monomers.
[0151] Inkjet printers generally employ print heads that may
contain 50 to 100 independently controlled nozzles. With each
nozzle operating at several hundred cycles per second (Hertz or
Hz), a machine with five such print heads can deliver the
appropriate reagents to 100,000 wells in a matter of seconds. A
complete synthesis cycle can take, for example, 5 minutes, or just
over 2 hours for an array of 100,000 biopolymers having 25 monomer
residues. Print heads having more or less nozzles and which operate
at different speeds can be used as well. Additionally, multiple
print heads can be simultaneously used to synthesize the biopolymer
arrays. Such configurations are known to those skilled in the art
and will vary depending on the size, format and intended use of the
array and the different reagents and monomers to be deposited.
[0152] FIG. 6 shows print head assembly 24. The print head assembly
comprises two print heads 36, mounted within an aluminum block 38.
The preferred print heads are inkjet print heads by Epson America,
Inc., of Torrance, Calif., sold as spare parts for use in STYLUS
COLOR II.TM. ink jet printers. These print heads are intended for
use in depositing a pattern of ink droplets onto media positioned
adjacent the print heads. More specifically, each print head
comprises an array of 60 individual nozzles, which are
piezoelectric pumps created with known etching techniques and
formed with small cavities with narrow inlets and nozzles, as
explained with respect to FIG. 3.
[0153] In this embodiment, the two print heads are aligned with
each other and directed upwardly, to deposit liquid on a substrate
that is positioned over the print heads. Block 38 and print heads
36 are supported on base 34 (FIG. 5) by calibration devices 39,
which include adjustments for height, rotation, pitch, and yaw.
Calibration devices 39 allow the print heads to be precisely
aligned with the mechanism, described below, that positions
substrates over the print head.
[0154] Each of the print heads has three separate fluid manifolds,
attached to the manifold inlets. When combined, the two print heads
have six manifolds, allowing the use of six different reagents.
External reservoirs 40 (FIG. 5) are connected to supply reagents to
the manifolds. Each print head has 60 nozzles organized as 3 banks
of 20 nozzles. The 20 nozzles in a bank have a common reagent
manifold. Each bank of nozzles is arranged linearly, along an axis
that is perpendicular to the direction in which the substrate is to
be moved across the print heads.
[0155] In the specific embodiment directed to the synthesis of
nucleic acid biopolymers, four manifolds contain different
nucleoside monomers as reagents. The monomers can be mixed with a
catalyst such as 5-methylthiotetrazole, tetrazole, or preferably
5-ethylthiotetrazole, in advance or, alternatively, another
manifold can be used to contain and apply the catalyst.
[0156] A complete synthesis cycle starts by delivering the
appropriate nucleoside monomers along with a catalyst such as
5-ethylthiotetrazole to the substrate. After a layer of monomers
are deposited on the substrate, the entire substrate is treated by
rinsing off excess monomers, exposing the substrate to an oxidizing
solution and then deprotecting for the next round of synthesis. The
rinses are common to all the loci on the substrate and can be done,
for example, by bulk immersion. One such cycle adds one monomer to
each oligonucleotide, thus a substrate of oligonucleotides having a
length of ten nucleosides requires 10 such cycles.
[0157] The number of cycles, and therefore, the length of the
biopolymer will be determined by the need and desired use of the
array. As such, the biopolymer lengths which can be achieved using
the automated system of the invention are only limited by the types
of reactive chemical species and existing coupling chemistries. For
nucleic acid biopolymers, oligonucleotides of unlimited length,
preferably between 10 and 100 monomers in length, and more
preferably between 20 and 60 monomers in length, can routinely be
synthesized.
[0158] For use in the automated synthesis system of the invention,
the biopolymer monomers may be either dissolved in a solvent or,
alternatively, the automated system can be adapted to contain a
mixing reservoir to supply a solvent. Thus, in the automated system
shown in FIG. 5, one or more of the external reservoirs 40 can
contain a solvent or monomers dissolved in a solvent. The solvent
is preferably one of the solvents described in Section 5.2.
[0159] Scanning transport 22 is used to "scan" a substrate by
moving the substrate over print head assembly 24 for depositing
nucleoside monomers at specified loci or sites on the substrate.
While print head control is accomplished in a manner similar to
that commonly employed with inkjet printers, unlike in a standard
inkjet printer the substrate is moved rather than the print head
assembly itself. As shown in FIG. 7, the scanning transport
comprises a translational stage having at least two axes of linear
movement. More specifically, the scanning transport is an X-Y
translation stage 41 oriented to provide two degrees of horizontal
motion. Movement along each axis is accomplished by an electronic
stepping motor that is geared to provide a linear resolution of
about 5 .mu.m. The preferred system uses an X-Y translation stage
from Parker Hannifin Corp, Model 310062AT.
[0160] To hold the substrate, scanning transport 22 includes a
vacuum chuck 42. Vacuum chuck 42 is mounted at the end of scanning
arm 44 that extends laterally from X-Y translation stage 41. The
vacuum chuck is connected relative to the X-Y translation stage so
that the vacuum chuck can be moved back and forth and sideways over
the print head.
[0161] The vacuum chuck includes a circular plate 46 having a
planar lower surface with a plurality of interconnected concentric
grooves (not shown). Vacuum is selectively applied to the
interconnected grooves to hold the substrate to the lower surface
of the vacuum chuck. To apply vacuum, a vacuum tube (not shown)
extends to the grooves from an external vacuum source that is
controlled by a solenoid valve (not shown). Circular plate 46 is
mounted for rotation within a mated opening in substrate holder 47
that is in turn attached to a distal end of scanning arm 44. The
opening preferably has a lower lip to support the circular plate 46
by its periphery from beneath. Clips (not shown) can be used to
retain the circular plate in its mated opening, and to provide
moderate friction that prevents accidental rotation of plate
46.
[0162] A small rotational adjustment pin 48 extends radially
outward from the circular plate, beyond substrate holder 47. The
rotational adjustment pin can be engaged to rotate circular plate
46 about a vertical axis.
[0163] The rotation feature of circular plate 46 is used to
rotationally calibrate a substrate relative to the print head. No
calibration is necessary for a substrate that is about to undergo
its first print head cycle because initial positioning of the
substrate with respect to the scanning transport is used to
establish an initial pattern of synthesis sites on the substrate.
During subsequent cycles, however, the substrate might be
positioned differently on the vacuum chuck, requiring calibration
steps. Horizontal position differences in position can be
compensated for by translational stage 41 and its controlling
electronics. Rotational misalignment (about the vertical z axis) is
corrected by rotating circular plate 46 within its substrate holder
47. Specifically, the scanning transport 22 is moved to engage
rotational adjustment pin 48 against a stationary vertical
reference pin (not shown) mounted next to the alignment unit 26. In
this fashion, rotating circular plate 46 can be rotated by an
amount that restores its original rotational alignment.
[0164] The amount of existing translational and rotational
misalignment is determined by alignment unit 26. FIG. 8 shows this
unit in more detail. Alignment unit 26 comprises a marker 50 and a
camera 52. Marker 50 can be activated to establish marks at
particular loci on the substrate for positionally calibrating the
substrate relative to the scanning transport and to the print head
assembly. It comprises a diamond tip or point that can be raised
and lowered in response to activation and deactivation of a
solenoid 54. When the marker is raised, it contacts an adjacent
substrate. If the substrate is moved with respect to the marker,
the marker scratches or scores the substrate, resulting in a
visible line.
[0165] The marker is mounted at an intermediate position along a
pivoting element 56 that is mounted at one end 57 for pivoting
about a horizontal axis. Solenoid 54 has a vertically movable
plunger 58 that engages the pivoting element at its other end
59.
[0166] Camera 52 comprises a lens unit 60 and a charged coupled
device (CCD) imaging element 61 that are used to positionally
calibrate the substrate relative to the scanning transport and to
the print head assembly. Marker 50, pivoting element 57, solenoid
54, and camera 52 are mounted to a block 62 that can be adjusted
vertically by means of a micrometer adjustment 63. This adjustment
is used to focus the lens and CCD combination on an adjacent
substrate. The preferred system uses a camera from Polaris
Industries, Model MB-810B Micro Size CCD.
[0167] In use, the initial positioning and alignment of a substrate
is recorded by scoring two marks on the substrate. Preferably, a
cross or X is made on two opposite ends or corners of the
substrate. During subsequent handling of a particular substrate,
each mark is positioned over lens 60 and its precise position is
recorded. This information is used to calculate horizontal
correction factors in the X and Y directions, and to calculate
rotational misalignment. The horizontal correction factors are used
when positioning the substrate over the print head with the
scanning transport 22. The rotational misalignment is corrected by
rotating circular plate 46 within its substrate holder 47 as
described above.
[0168] FIG. 9 shows flow cell 30. Flow cell 30 is adapted for
receiving the substrate and for "treating" the substrate by
exposing the substrate to one or more selected reagents.
Specifically, it is used for washing off unattached monomers,
exposing the substrate to an oxidizing solution, and deprotecting
the terminal nucleoside of the oligonucleotides being formed for
the next round of synthesis.
[0169] In a preferred embodiment, flow cell 30 includes a
rectangularly shaped stationary plate 70 mounted perpendicularly to
base 34. A square backing plate 76 which is oriented parallel to
stationary plate 70 is fixed to stationary plate 70 with four
cylindrical rods 77. A square moving plate 72 that is parallel to
and located between stationary plate 70 and backing plate 76 moves
back and forth between these fixed plates guided by the rods 77.
Each rod 77 fits through a hole located near a corner of moving
plate 72. The holes are sized to rods 77 for a close sliding fit.
One end of each rod 77 is fixed near a corner of backing plate 76.
The other end of each rod 77 is fixed to stationary plate 70. When
moving plate 72 moves toward stationary plate 70, a substrate is
sandwiched between the two plates. Moving plate 72 is driven by a
pneumatic cylinder 74 whose longitudinal axis is parallel to the
direction of travel of moving plate 72. The base of pneumatic
cylinder 74 is fixed to backing plate 76 and the end of piston rod
79 of pneumatic cylinder 74 is fixed to moving plate 72. Moving
plate 72 is guided by the rods 77 to slide toward and away from
stationary plate 70 in response to activation of pneumatic cylinder
74.
[0170] A vertical surface 80 of stationary plate 70 which faces
moving plate 72 has a raised circular ring 82 made of a material
that can withstand contact with the solvents used to treat the
substrate. The raised circular ring 82 is sufficiently large in
diameter to surround all portions of a substrate upon which
reagents have been deposited. An inlet 83 extends through
stationary plate 70 just inside the raised circular ring 82 at its
lowermost portion and an outlet 84 extends through the stationary
plate 70 just inside the raised circular ring 82 at its uppermost
portion.
[0171] The planar surface of moving plate 72 facing stationary
plate 70 has embedded in it a rubber o-ring (not shown) which
protrudes above the surface of moving plate 72 and can press a
substrate against raised circular ring 82. The rubber o-ring is the
same diameter as the circular ring 82 so as to directly transfer
pressure to the surface of the circular ring 82 and not to crack
the substrate that is held between the o-ring and circular ring 82.
A substrate so pressed against raised circular ring 82 forms a
sealed chamber that is bounded by the surface of the substrate, by
vertical surface 80, and by raised circular ring 82. The surface of
the substrate forming a portion of the chamber can be exposed to
various solvents by injecting such solvents into the chamber
through inlet 83. The solvents exit the chamber through outlet 84.
This aspect of the invention is automated by utilizing solenoid
controlled valves in conjunction with solvent containers and
appropriate tubing (not shown).
[0172] Treating transport 23 which is used for placing a substrate
within the flow cell 30 comprises an X-Y translation stage, an
elevator 86 that provides vertical (Z axis) movement, and a rotator
87 to provide motorized rotational movement about the longitudinal
axis of an elongated rod 90 which extends from rotator 87. Movement
along each of the X, Y, Z, and rotational axes is controlled by a
stepping motor. The treating transport 23 also includes a vacuum
chuck 91 which is attached to the end of the elongated rod 90
distal from the rotator 87. The vacuum chuck 91 has a circular
shape that is approximately the size of the substrate upon which
synthesis is being performed. The vacuum chuck 91 is thus
configured to hold the surface of the substrate away from the
surface on which reagents are being deposited. The vacuum chuck 91
is relatively thin so that it can be positioned conveniently
between stationary plate 70 and moving plate 72 of flow cell 30. By
controlling the X-Y translation stage, the elevator 86, and the
rotator 87, vacuum chuck 91 can be moved along two horizontal axes
and a vertical axis, and can also be rotated about one of the
horizontal axes.
[0173] When vacuum chuck 91 positions a substrate between circular
ring 82 and the surface of moving plate 72, a low vacuum of
approximately three feet of water (1.3 pounds per square inch) is
created within the chamber formed by the substrate, vertical
surface 80, and circular ring 82. This slow vacuum holds the
substrate in place after the vacuum chuck 91 retracts and before
moving plate 72 moves in to firmly press the substrate against
circular ring 82.
[0174] Transfer station 28, shown in more detail in FIG. 10, serves
an intermediate holding location for the substrate when the
substrate is transferred between scanning transport 22 and treating
transport 23. Transfer station 28 includes a planar motorized
platform 93 oriented parallel to base 34 that supports a planar
vacuum chuck 94. Vacuum chuck 94 has a square upper surface
oriented parallel to motorized platform 93 upon which a substrate
can rest. Vacuum is applied about the periphery of the upper
surface of vacuum chuck 94 to secure the substrate when the
substrate is placed on vacuum chuck 94.
[0175] Vacuum chuck 94 is supported on top of motorized platform 93
by four coil springs 95 which are located between the motorized
platform 93 and the vacuum chuck 94. One coil spring 95 is
positioned near each of the corners of vacuum chuck 94. Motorized
platform 93 can be raised and lowered by a stepping motor 96 which
is located below motorized platform 93. Vacuum is communicated to
vacuum chuck 94 by a vacuum line 97, which communicates the vacuum
by a solenoid controlled valve (not shown). To receive a substrate
held by vacuum chuck 42 of scanning transport 22, the motorized
platform 93 is raised until the upper surface of vacuum chuck 94
contacts the lower surface of the substrate. Motorized platform 93
does not have to move vertically to transfer a substrate to or from
vacuum chuck 91 of treating transport 23 since that mechanism has
vertical movement capability. Coil spring 95 absorbs any
over-travel of motorized platform 93. Once the substrate has been
grasped by vacuum chuck 94, motorized platform 93 is lowered.
[0176] FIG. 11 shows control components used to manipulate the
various electromechanical components described above. Such
components include a computer 100 having a microprocessor and
associated memory components such as electronic memory and mass
storage devices. The preferred system uses an IBM-compatible
computer. Computer 100 includes common user interface components
such as a monitor, a keyboard, and a mouse. The computer also has
an expansion bus allowing various specialized peripheral devices
and interfaces to be used in conjunction with the computer.
[0177] Various electronic hardware is provided for use in
conjunction with computer 100 for actuating solenoids, stepping
motors, and other components that control the physical operation of
the hardware described above. Some of these components are
implemented on expansion cards that are plugged directly into the
expansion bus of computer 100, while other components are external
to computer 100. The specific design and configuration of these
electronic components will vary depending upon the particular
electromechanical components used. As an example, the control
components of FIG. 11 include a digital I/O card 102 having a
plurality of digital inputs and outputs. This card is plugged
directly into the expansion bus of computer 100. External driver
circuits 104 are used as a buffer between the computer-level
signals of I/O card 102 and the higher level signals used by the
electromechanical components themselves. Solenoids are controlled
with outputs from I/O card 102.
[0178] A frame capture circuit 110 is plugged into the expansion
bus of computer 100. Frame capture circuit 110 receives a video
signal from camera 52 and provides a two-dimensional array of pixel
values for use by computer 100. Frame capture circuit 110 and the
digital image it produces are used to locate the substrate marks
made by marker 50 and to thereby determine any necessary
compensation in positioning the substrate with respect to the print
head. The preferred system uses a frame capture circuit on a
WinVision Video capture board from Quanta Corp.
[0179] A plurality of motion control cards 106 are also plugged
into the expansion bus of computer 100. These are conventional
stepping motor control cards that operate in conjunction with
computer 100 to control movements of the various stepping motors
described above. The preferred system uses motion control cards
from Oregon Micro Systems Inc., Model PC34-4. External driver
circuits or amplifiers 108 are electrically connected between the
motion control cards and the stepping motors themselves.
[0180] A print head controller 109 is also plugged into the
expansion bus of computer 100. This circuit has electrical drivers
that are configured specifically for the particular print heads
that are chosen for use in print head assembly 24. In many cases,
it will be necessary for these drivers to receive position feedback
signals from the motion control circuits controlling the scanning
transport 22, in order to coordinate print head firing with
progress of the substrate across the print head assembly.
[0181] FIG. 12 shows in detail printer head controller 109 for
controlling the inkjet printer heads. Trigger RAM 201 stores
X-positions of the substrate where the deposition is to take place.
Quadrature decoder & counter 202 produces the current
X-position of the substrate by decoding the signal from a stepping
motor used to move the substrate. Equality test 203 compares the
current X-position with the X-position of deposition and produces a
match signal. The match signal is provided to timing logic 204,
which generates various timing signals to synchronize the
activities across the components. Timing logic 204 uses 16-bit
counter 205 to generate address signals to access the trigger RAM
201 as well as spit vector RAM 206. The spit vector RAM 206 stores
a bit map for each trigger point where each bit represent the
activation of a nozzle. The bitmap is loaded to each head using
parallel-load shift registers 207 and 208. Timing logic 204 also
uses 16-bit counter 209 to generate an address signal to access
waveform RAM 210, which contains data representing the electric
pulse waveform supplied to the print head. The waveform data are
loaded to 8-bit latches 211 and 212 and converted to pulse signals
using digital-to-analog (D-to-A) converters 213 and 214.
[0182] Computer 100 is programmed using conventional programming
techniques to control movement of the various moving parts
described above. Other types of computers or control logic could of
course be used in place of the computer described. For example, an
industrial-control computer unit referred to as a programmable
controller might be substituted in place of a desktop computer.
[0183] Computer 100 is programmed specifically to move substrates
between rack 32 and the two processing components: print head
assembly 24 and flow cell 30. With respect to a single substrate, a
first step might comprise retrieving the substrate from rack 32
with treating transport 23 and moving the substrate to transfer
station 28. Rack 32 has slots for receiving and storing substrates
in vertical orientations. Other orientations can be equally
substituted. Since substrates are stored vertically in rack 32,
vacuum chuck 90 of treating transport 23 is turned to a vertical
orientation and moved adjacent the rear surface of the substrate.
Vacuum is applied to vacuum chuck 91 by activating a solenoid
valve, and vacuum chuck 91 is withdrawn from rack 32 along with the
substrate.
[0184] Vacuum chuck 91 is then rotated to a horizontal orientation
and moved to a position over transfer station 28. Vacuum chuck 91
is lowered to place the substrate on vacuum chuck 94. Vacuum is
applied to vacuum chuck 94 of transport station 28 by activating a
solenoid valve. The vacuum is disconnected from vacuum chuck
91.
[0185] Vacuum chuck 42 of scanning transport 22 is then moved over
the substrate, and the substrate is raised by transfer station 28
so that it engages vacuum chuck 42. Vacuum is applied to vacuum
chuck 42 by activating a solenoid valve.
[0186] If this is the initial cycling of the substrate, it is moved
over marker 50 to establish one or more calibration marks on the
substrate as already described. The substrate is then moved over
print head assembly 24.
[0187] If the substrate has already been cycled over the print
head, the substrate is moved over camera 52 while computer 100
performs a step of locating the marks in conjunction with the
camera. Accordingly, each mark is located individually. That is,
one of the two marks is positioned within the camera's field of
view and an image is acquired by computer 100. This is repeated
with the other mark. Using the two acquired images that include the
marks, the computer determines the position of the substrate
relative to X-Y translation stage 41 and in relation to its initial
position as represented by the marks. The computer then performs a
software calibration of X-Y translation stage 41 to account for any
difference in the position of the substrate in comparison to its
original position.
[0188] The computer also determines the rotational misalignment of
the substrate with reference to the marks, again using the acquired
images. In response to any rotational misalignment, the computer
moves X-Y translational stage 41 to engage rotational adjustment
pin 48 of the vacuum chuck 42 with the vertical reference pin to
rotate the circular plate 46 of vacuum chuck 42 by an angular
displacement that corrects for the misalignment.
[0189] Once the substrate has been positionally calibrated, the
computer moves the substrate over print head assembly 24 with
scanning transport 22 while simultaneously firing print head 36
repeatedly to deposit the nucleoside monomers at appropriate sites.
Multiple passes might be required to reach all the sites of the
substrate. Further passes are made to apply a catalyst. The
computer then moves the substrate to transfer station 28 with
scanning transport 22. Treating transport 23 is then moved to
transfer station 28 to pick up the substrate. Vacuum chuck 91 of
treating transport 23 carries the substrate to flow cell 30 and
positions it therein. A low vacuum of approximately three feet of
water (1.3 pounds per square inch) is applied to the chamber formed
by the substrate, vertical surface 80, and circular ring 82. This
low pressure holds the substrate in place while the vacuum chuck 91
retracts. Moving plate 72 then clamps the substrate firmly in the
flow cell 30. Rinsing solvents are then cycled through flow cell
30. The substrate is then released from the flow cell. If
processing is complete, treating transport 23 moves the substrate
back to rack 32. Otherwise, the steps above are repeated.
SOFTWARE IMPLEMENTATION
[0190] Flow charts detailing the operation of the software
controlling the automated system are depicted in FIGS. 13-21. Here,
while "wafer" is used to describe a specific example of a
substrate, it will be clear that other substrates may also be
used.
[0191] FIG. 13 shows in detail the steps for the initialization of
the program. After the program starts at step 1000, it reads in the
file storing the pump driving waveforms describing voltage
waveforms for activating the piezoelectric pumps in the inkjet
print head (step 1001). Next, the program reads in the file
describing the print head geometry describing how the nozzles in
the print head are spaced and the contents of each manifold
connected to the nozzles (step 1002). Next, the program initializes
the mapping from individual nozzles on the inkjet print heads to
bits in the spit vector RAM (step 1004). The program then reads in
a list containing the name of an oligo specification file storing
the geometry of the desired pattern to be deposited in a particular
wafer to be processed in a particular run (step 1005).
[0192] If the program is done with wafer-specific initialization,
it proceeds to the main loop in step 1007. Otherwise, the program
reads the oligo specification file storing the geometry of the
desired pattern to be deposited in a particular wafer (step 1008).
The program then calculates all trigger RAM 201 entries that will
be used, which include a distinct inkjet nozzle trigger point
(X-location) and a distinct column of dots in the pattern on a
wafer at each trigger point (step 1009). The program then
calculates all Y-positions (passes) that the scanning arm will need
to make in the course of synthesizing one layer of nucleoside
monomers (step 1010). During the operation, the scanning arm moves
to Y-positions, then sweeps across the X-positions required to trip
all the desired trigger points. The required Y-positions are
determined by the number and spacing of the rows of dots in the
desired pattern and the space spanned by a column of inkjet nozzles
on an inkjet print head. The program also determines the number of
times the trigger RAM 201 will need to be reloaded while scanning
one layer of nucleoside monomers. The program maps each row in the
directed wafer pattern to what will be the nearest row of nozzles
during the appropriate Y-pass (step 1011).
[0193] FIG. 14 shows the main loop involving the operation of the
automated synthesis system. In the case where there are multiple
flow cells, the program first determines whether all flow cells
were checked (step 1100). If they were not, it checks each flow
cell to see whether it is done with treating the wafer (steps
1104-1106). If the treatment is done, the wafer is transferred to
scanning 44 arm if the scanning arm is empty.
[0194] If all the flow cells were checked, the program checks
whether there is a wafer on the scanning arm (step 1101). If there
is, it proceeds to the Check_Alignment routine (step 1109) where it
does initial positioning and alignment of the wafer. If there is no
longer a wafer on the scanning arm (i.e., it was removed during the
Check_Alignment routine) or there wasn't to start with (step 1111),
the program checks whether the number of wafers in the system is
less than the number of flow cells minus 1, i.e., whether all the
flow cells are not full. If all the flow cells are not full, the
system loads the next wafer from wafer rack 32 (steps
1102-1103).
[0195] FIG. 15 shows the Check_Alignment routine in detail. The
program checks whether the wafer had been aligned previously (step
1200) after its most recent transfer to the scanning arm. If so,
the program checks whether the wafer is to receive the first layer
of deposition (step 1201). If it is, the program executes a routine
for "tagging" the wafer, i.e., making registration marks for
subsequent re-alignment (step 1202), which will be described in
more detail with reference to FIG. 12. The program then executes a
routine for aligning the wafer (step 1203), which will also be
described in more detail with reference to FIG. 12.
[0196] If the wafer had been aligned before, the program checks
whether the wafer has been just aligned (step 1204). If so, the
program checks whether all the layers on the wafer are done (step
1205). If so, the wafer is transferred back to the wafer storage
rack (step 1206). Otherwise, the program executes the Do_a_layer
routine for depositing a layer on the wafer (step 1207). If the
wafer has not been just aligned, i.e., the deposition has just been
finished, the wafer is transferred to an empty flow cell (step
1209) and the treatment of the wafer starts (step 1209).
[0197] FIG. 16 shows in detail the routine for tagging the wafer
and the routine for aligning the wafer.
[0198] The routine for tagging the wafer by scoring registration
marks consists of steps 1300-1304. The rotational position of
vacuum chuck 42 is initialized by bumping rotational adjustment pin
48 against the vertical reference pin to return the adjustment pin
to a known location (step 1300). The scanning arm moves the wafer
to a location for the first registration mark on the wafer (step
1301). A cross is cut on the wafer by coordinating the movement of
the scanning arm with the activation of solenoid 54 for raising the
scribe tip (step 1302). Scanning arm 44 moves the wafer to another
location for the second registration mark (step 1303). Another
cross is cut on the wafer (step 1304).
[0199] The routine for aligning the wafer once the registration
marks are scored on the wafer consists of steps 1305-1404. Vacuum
chuck 42 is initialized by bumping rotational adjustment pin 48
against the vertical reference pin to return the adjustment pin to
a known location (step 1305). Scanning arm 44 moves the wafer such
that the first registration mark will be centered over the center
of camera 52 if the alignment was already correct (step 1306). This
should place the registration mark somewhere in the camera's field
of view. The center position of the cross of the first registration
mark is measured (step 1307). Scanning arm 44 moves the wafer such
that the second registration mark on the wafer will be centered
over the center of the camera if the alignment was already correct
(step 1308). The center position of the cross of the second
registration mark is measured (step 1309). The program calculates
the angle that the wafer is rotated away from a perfectly aligned
position from the measured positions of the two registration marks
(step 1400). The program then calculates the direction and the
magnitude of the deflection of rotational adjustment pin 48
required to correct the above rotation (step 1401). The rotational
adjustment pin is bumped against the vertical reference pin to
correct the rotation (step 1402). The scanning arm moves the wafer
so that the second registration mark is now over the center of the
camera (step 1403). The program executes the Go_home routine for
calculating the X and Y-position adjustments such that the center
of the registration mark is located directly over the center of the
camera (step 1404).
[0200] FIG. 17 shows the Go_home routine in detail. The program
first checks whether the second registration mark is at the home
position, i.e., being centered over the center of the camera (step
1501). If it is not, the position of the second registration mark
is recorded and the scanning arm moves the wafer to two locations
that leave the second registration mark in the field of view to
measure how movements of the scanning arm cause the position of the
second registration mark to vary the camera's frame of reference
(steps 1502-1508). The program then calculates the angle of the
camera relative to the stepping motor axes from the measured
positions of the registration marks and the known change in
position of the scanning arm (step 1509). The wafer is moved by
calculating the amount needed to move the wafer to get to the home
position given the camera angle and the apparent displacement of
the second registration mark from the home position (step 1510).
The program checks whether the wafer is at the home position (steps
1511-1512). If the wafer is not in the home position, the program
repeats steps 1510-1512.
[0201] FIG. 18 shows the routine for controlling the treatment in a
flow cell, including rinsing and deprotection of a wafer. When the
first step of treatment starts (step 1600), a timer is set for the
duration of the treatment (step 1601). When the time expires, the
timer calls the do_alrm routine which checks whether all the
treatment steps are done (step 1603). If so, the do_alrm routine
indicates this to the program (step 1604). If not, the next
treatment is started (step 1605), and a timer is set for the
duration of the treatment as before (step 1606).
[0202] FIG. 19 shows in detail a routine for measuring the center
position of the first or second registration mark. The program
first obtains from the frame capture circuit a two-dimensional
array of pixels of a digital image taken by the camera (step 1702).
Typically, the registration mark will not be rotated more than one
degree or so from its aligned position. A semi-vertical line and a
semi-horizontal line can be identified from the array of pixels
because one of the two lines in the registration mark will appear
to be vertical and the other to be horizontal. The program
calculates the equation for the semi-vertical line (step 1703).
Similarly, the program calculates the equation for the
semi-horizonal line (step 1704). The program then calculates the
intersection of the two lines and records the position (step 1705).
If the current and previous calculations of the position of the
registration mark agree within some tolerance, the program returns
the calculated position as the center position of the registration
mark (steps 1707-1708). If they don't agree or any of the steps
requires to estimate the position fails, the program re-tries at
step 1701.
[0203] FIG. 20 shows in detail the programming steps for
calculating the equation of the semi-vertical line or the
semi-horizontal line. First, the pixel values are adjusted against
the background (step 1801) by subtracting the background intensity
from each pixel in order to compensate the effect of different
lighting backgrounds. Then, for each row or column of the picture
(whichever is perpendicular to the expected line), the program
finds the location of the pixel of the maximum intensity (step
1802). The program makes a histogram of the positions calculated
above and discards the positions below an occurrence frequency
cutoff value (step 1803). The program performs a regression on the
remaining points to get the equation for a line (step 1804). The
program calculates the standard deviation of the points from the
regression line (step 1805). The program throws away those points
whose distance from the regression line is large compared to the
standard deviation calculated in the last step (step 1806). The
program performs a regression on the remaining points to get
another equation. If the last two equations calculated agree within
a certain tolerance, the program returns the equation (steps
1807-1809). The program continues the cycle of discarding points
and regressing until either successive equations agree, or too few
points remain.
[0204] FIG. 21 shows in detail the programming steps necessary for
the Do_a_layer routine that controls the printer head and the
scanning arm to deposit a particular layer. The scanning arm moves
the wafer such that the upper right corner of the wafer just
overlaps the top row of the nozzles in the first inkjet print head
(step 1900). The program then reads in the oligo specification file
containing the oligonucleotide sequences for the wafer and extracts
the nucleoside specification for the current layer (step 1901). The
program then calculates the entire contents of the spit vector RAM
for this layer from the information obtained in previous steps
(step 1902). The spit vector RAM contains spit vectors representing
information of how to fire the array of nozzles at each trigger
point (X-position).
[0205] Once the scanning (deposition) of the current layer has been
done, the chemicals are allowed to dry and the wafer is placed on a
wafer elevator (steps 1904-1905). If the scanning has not been
done, the program loads into the spit vector RAM the appropriate
portion of the spit vectors from step 1902 for the part of the next
layer to scan. The program then loads the trigger RAM with the
X-locations calculated for that wafer during the initialization
(step 1907). The wafer is scanned back and forth the appropriate
number of times at the appropriate Y-locations as calculated in
step 1010 (step 1908).
EXAMPLE 1
Comparison of Result of Oligonucleotide Synthesis With Propylene
Carbonate vs. Acetonitrile Solvent
[0206] Nucleoside phosphoramidites used in this experiment are of
the EXPEDITE.TM. type, and were obtained from Perseptive
Biosystems, Framingham, Mass. The primary amino groups of the base
portion of the adenosine (A), cytidine (C) and guanosine (G)
nucleosides were protected with t-butylphenoxyacetyl (tBPA) groups.
The 5'-hydroxyl groups of the A, C, G and thymidine (T) nucleosides
were protected with a dimethoxytrityl (DMT) group. The 3'-hydroxyl
groups of the A, C, G and T nucleosides were derivatized as
.beta.-cyanoethyl-N,N-diisopropylphosphoramidites.
[0207] This example compares the efficiency of nucleoside coupling
when propylene carbonate is used as a reaction solvent, relative to
that when acetonitrile is used, in conventional, solid phase
nucleoside synthesis.
[0208] As shown below in Table 1, eight separate oligonucleotide
homopolymers of A, T, C and G, each being eleven nucleotides in
length, were assembled using either propylene carbonate or
acetonitrile as the reaction solvent. Reagents were dispensed from
an Applied Biosystems model 380B synthesizer, a non-inkjet
synthesizer, using phosphoramidite chemistry according the
manufacturer's instructions. A trityl assay (see T. Atkinson et
al., Solid-Phase Synthesis of Oligodeoxyribonucleotides by the
Phosphite-Triester Method, in Oligonucleotide Synthesis (M. J. Gait
ed., 1984)) was used to estimate stepwise yields on all eight
syntheses. This assay measures the amount of dimethoxytrityl group
released during the deprotection step of the synthetic cycle. The
measurement is conveniently carried out photometrically since the
dimethoxytrityl group absorbs light strongly at 498 nm. Using this
assay, an estimate of the efficiency of the synthetic reactions was
made by comparing the amounts of dimethoxytrityl released from one
cycle to the next. As shown in Table 1, yields of oligonucleotides
that are obtained using either propylene carbonate or acetonitrile
solvents, are comparable.
1TABLE 1 Assembly of oligonucleotide homopolymers using
acetonitrile or propylene carbonate polydT polydG polydA polydC %
yield A* PC A PC A PC A PC Average 99.4 99.6 99.3 97.4 97.8 96.6
98.9 98.4 Overall 88.8 89.4 87.6 74.1 77.6 65.9 88.8 85.4 Stepwise
98.8 98.9 98.7 97.0 97.5 95.9 98.8 98.4 *A = Acetonitrile; PC =
Propylene Carbonate
EXAMPLE 2
Synthesis of Two-Dimensional Oligonucleotide Arrays Using an Inklet
Print Head
[0209] This example describes the synthesis of a two-dimensional
array of oligonucleotides using the synthesis system described in
Section 5.5.1. With respect to the steps involving deposition of
reagents using an inkjet printing head, i.e., those steps not
involving oxidizing, rinsing, capping and deprotection, an earlier
version of the software described in Section 5.5.2 was used.
[0210] The nucleoside phosphoramidites used in this experiment were
those described in Section 6, above.
[0211] An oxidizing solution, that was used to oxidize nucleoside
phosphite triesters to nucleoside phosphate triesters, consisted of
90.54% (v/v) tetrahydrofuran, 9.05% (v/v) water, 0.41% (v/v)
pyridine and 4.3 g/L iodine.
[0212] As mentioned before, inkjet print heads used herein were
EPSON STYLUS COLOR II.TM. color heads, available from the
manufacturer as spare parts, which consist of three banks of twenty
nozzles each. All of the nozzles in each bank were connected to a
common fluid intake manifold, such that each inkjet print head had
three fluid lines connected thereto. The complete inkjet assembly
consisted of two inkjet print heads mounted together, so as to form
an assembly of six banks of twenty nozzles each.
[0213] Fifty clean, standard, glass microscope slides (25
mm.times.75 mm) were used as the substrates upon which the
oligonucleotide arrays were assembled, and were derivatized
according to the procedure of E. M. Southern et al., Genomics
13(4):1008-1017 (1992). The slides were submerged in a bath of 200
mL of glycidoxypropyltrimethoxysilane, 800 mL of anhydrous xylenes
and 10 mL of diisopropylethylamine for 8 h at 80.degree. C. with
stirring, and then rinsed with ethanol and dried under nitrogen.
The resulting substrates were placed in a bath of 800 mL of
tetraethylene glycol and 3 mL of conc. H.sub.2SO.sub.4 for 8 h at
80.degree. C. with stirring, and then rinsed with ethanol and dried
under nitrogen.
[0214] Four of the six inkjet banks of the assembly were loaded
with 0.1 M solutions (propylene carbonate) of each nucleoside
phosphoramidite and one of those six inkjet banks was loaded with a
0.5 M solution of 5-ethylthiotetrazole in propylene carbonate.
[0215] The derivatized substrate was affixed to an X-Y translation
stage that was driven by two stepping motors via a lead screw. A
computer, along with an appropriate electronic interface, was used
to synchronize the firing of the inkjet print head with the motion
of the X-Y translation stage, so as to deliver one 42 pL drop of
the appropriate nucleoside phosphoramidite solution, followed by
one 42 pL drop of the 5-ethylthiotetrazole solution to each region
of the substrate where oligonucleotide synthesis was to take place.
This reaction, which resulted in the coupling of each nucleoside to
the substrate via a tetraethyleneglycol linker, was allowed to
proceed for 60 seconds under a nitrogen atmosphere. The substrate
was rinsed with acetonitrile to remove excess reagents, and dried
with anhydrous nitrogen.
[0216] The resulting substrate was submerged in a bath of the
oxidizing solution for 30 seconds so as to convert the resulting
nucleoside phosphite triesters to nucleoside phosphate triesters.
The substrate was then rinsed again with acetonitrile, and then
treated with a solution of 20 .mu.L of perfluorooctanoyl chloride
in 50 mL of anhydrous xylene, so as to cap all of the unreacted
hydroxyl groups of the tetraethylene glycol bonded to the
substrate.
[0217] The resulting substrate was rinsed with acetonitrile, dried
with anhydrous nitrogen, and then dipped for 60 seconds in a
solution of 2.5% dichloroacetic acid in dichloromethane which
removed the dimethoxytrityl protecting group from the 5'-hydroxyl
group of nucleoside. After a final rinse with acetonitrile, and a
drying stream of dry nitrogen, the substrate was subjected to 19
iterations of the (a) nucleoside coupling, (b) acetonitrile
rinsing, (c) oxidation, (d) acetonitrile rinsing, (e)
dimethoxytrityl deprotecting and (f) acetonitrile rinsing
steps.
[0218] Finally, the substrate was dipped in undiluted ethanolamine
for 20 minutes, at room temperature, to remove both the tBPA
protecting groups from the nucleoside bases, and the cyanoethyl
groups from the phosphate linkages between adjacent to nucleosides
to provide phosphate groups. The substrate was then rinsed with
ethanol, and then with acetonitrile, leaving the resulting
oligonucleotide attached to the substrate.
[0219] The present invention is not to be limited in scope by the
specific embodiments disclosed in the examples which are intended
as illustrations of a few aspects of the invention, and any
embodiments which are functionally equivalent are within the scope
of this invention. Indeed, various modifications of the invention,
in addition to those shown and described herein, will become
apparent to those skilled in the art, and are intended to fall
within the appended claims.
[0220] A number of references have been cited, and the entire
disclosures of which are incorporated herein by reference.
* * * * *
References